Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3035400	s-afmaksa	U/l (u/l)	2233	2793	0.00%
3035400	s-afmaksa	— (—)	464	494	100.00%	Distribution not available
3035400	s-afmaksa	U/l_______ (u/l)	147	164	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dialysis, with operation codes

301

241

13.15

310.38

1.5

1.2

112.39

89.52

u/l

1.49

272

198

ILD medications: immunosuppressive drugs

714

1341

4.89

308.91

1.3

1.2

91.12

90.85

u/l

0.01

626

1147

Diseases of liver

533

890

6.14

303.93

1.3

1.2

122.81

83.74

u/l

7.05

484

740

Chronic kidney disease

464

711

6.43

273.13

1.4

1.3

115.71

93.92

u/l

1.21

409

584

Nephropathy related operations

281

255

11.59

267.44

1.5

1.2

126.22

96.53

u/l

0.99

255

213

Renal failure

597

1035

5.00

258.77

1.3

1.2

118.85

93.08

u/l

2.20

530

866

Care involving dialysis

214

146

15.57

242.44

1.5

1.2

99.92

101.78

u/l

0.05

193

117

Transplanted organ and tissue status

222

173

13.48

232.61

1.4

1.1

127.60

83.26

u/l

1.25

200

143

All chronic kidney diseases

609

1079

4.57

232.33

1.3

1.2

112.86

86.06

u/l

2.58

538

911

Autoimmune diseases excluding thyroid diseases

882

1325

3.64

218.79

1.3

1.2

103.33

90.99

u/l

1.61

773

1121

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

872

1727

3.43

215.57

1.3

1.2

113.82

86.41

u/l

3.88

776

1461

Autoimmune diseases excluding thyroid diseases, strict definition

851

1266

3.69

215.27

1.3

1.2

104.15

90.99

u/l

1.70

746

1067

L04AD Calcineurin inhibitors

234

225

10.89

213.97

1.4

1.2

116.01

84.88

u/l

0.87

209

187

Renal tubulo-interstitial diseases

793

1686

3.48

205.36

1.3

1.2

116.44

86.95

u/l

4.01

704

1430

Anaemias

242

125

12.60

188.86

1.3

1.2

120.56

72.22

u/l

1.94

217

101

All kidney diseases

811

1708

3.21

180.40

1.3

1.2

110.85

87.18

u/l

2.86

711

1455

ILD medications

860

1457

3.20

177.46

1.3

1.2

99.75

92.70

u/l

0.49

747

1252

Fibrosis and cirrhosis of liver

184

168

11.55

174.57

1.5

1.1

137.97

77.74

u/l

5.62

170

142

L04AA Selective immunosuppressants

323

576

5.75

172.28

1.3

1.2

108.22

89.43

u/l

0.66

286

483

Preparatory care for dialysis

140

18.53

172.09

1.4

1.2

86.24

97.85

u/l

0.43

125

First line medication for Crohn's disease

825

1392

3.21

170.74

1.3

1.2

102.17

91.11

u/l

0.85

718

1183

Autoimmune diseases related-to ILD

731

1941

3.17

170.51

1.3

1.2

92.42

94.01

u/l

0.13

636

1665

ILD medications: prednisolone, methylprednisolone, prednisone

822

1446

3.18

169.79

1.4

1.2

101.52

93.13

u/l

0.58

707

1242

Bacterial infection, other or unspecified, including avohilmo

569

1262

3.74

169.23

1.4

1.2

114.10

87.73

u/l

4.19

530

1052

Other bacterial diseases

785

1689

3.10

165.10

1.3

1.2

117.51

84.71

u/l

4.67

705

1420

Bacterial infection, other or unspecified

533

1191

3.82

165.03

1.3

1.2

116.67

87.66

u/l

4.57

498

990

Other diseases of liver

279

455

6.30

163.31

1.3

1.2

119.08

78.99

u/l

4.01

255

383

Inflammatory bowel disease treatment related agents

855

1637

2.92

153.27

1.3

1.2

95.15

93.02

u/l

0.17

737

1412

Kidney transplant status

138

14.84

152.12

1.5

1.2

119.64

89.74

u/l

0.42

121

Other bacterial diseases, including avohilmo

794

1684

2.96

152.07

1.3

1.2

113.73

83.40

u/l

4.15

711

1420

IBD patients in KELA-register

282

498

5.78

151.81

1.4

1.2

80.32

87.49

u/l

0.46

234

421

Heart failure, not strict

644

1336

3.27

147.96

1.3

1.2

108.03

85.03

u/l

4.16

569

1125

ILD medications: azathioprine

202

262

7.90

146.08

1.4

1.2

91.60

90.99

u/l

0.02

173

221

Primary biliary cholangitis (PBC)

33.23

145.81

1.5

1.1

131.07

73.59

u/l

4.08

Inflammatory bowel disease, strict (require KELA)

282

522

5.51

144.33

1.4

1.2

80.32

89.39

u/l

0.63

234

444

Extracorporeal dialysis

143

119

12.71

144.16

1.6

1.2

107.36

92.46

u/l

0.45

128

105

Tramadol

641

1198

3.24

140.24

1.3

1.2

97.94

88.89

u/l

1.04

554

1023

Azathioprine

202

281

7.37

137.42

1.4

1.2

91.60

89.68

u/l

0.06

173

239

5-aminosalicylic acid

251

440

5.81

136.18

1.4

1.2

87.37

85.70

u/l

0.07

209

376

Glomerular disorders in diseases classified elsewhere

187

247

7.82

133.41

1.5

1.2

106.90

98.61

u/l

0.36

175

205

Examination and observation for other reasons

504

765

3.75

132.65

1.2

94.21

89.93

u/l

0.32

448

650

Second line medication for Crohn's disease

521

1629

3.23

131.04

1.3

1.2

79.31

94.39

u/l

2.39

455

1392

Dental caries

289

553

5.01

130.69

1.4

1.2

113.40

94.35

u/l

1.31

259

462

Noninfective enteritis and colitis

438

1232

3.59

130.29

1.4

1.2

87.53

90.04

u/l

0.17

373

1036

Bacterial Sepsis

455

1058

3.60

128.58

1.4

1.2

119.28

87.77

u/l

4.14

409

894

Inflammatory bowel disease

336

793

4.30

128.46

1.4

1.2

81.16

87.49

u/l

0.49

283

674

Mucosal proctocolitis

182

244

7.66

128.01

1.4

1.2

89.25

86.46

u/l

0.11

153

200

Primary Sclerosing Cholangitis, IBD and UDCA required

28.74

126.14

1.3

1.2

131.51

66.43

u/l

3.77

Glomerular diseases

232

408

5.82

125.67

1.4

1.2

101.15

93.18

u/l

0.45

213

338

Septicaemia

396

965

3.79

124.06

1.3

1.2

133.26

89.11

u/l

2.94

357

797

Abnormal findings on examination of blood, without diagnosis

432

1113

3.55

123.11

1.3

1.2

118.09

94.75

u/l

2.62

380

933

Autoimmune diseases

741

1338

2.83

122.40

1.3

1.2

97.77

90.90

u/l

0.65

648

1130

Implicit bacterial Sepsis

407

954

3.70

121.27

1.4

1.2

121.44

87.49

u/l

4.10

365

803

Ulcer of lower limb, not elsewhere classified

202

325

6.38

119.90

1.4

1.2

119.43

91.27

u/l

2.35

183

268

Budesonide

195

304

6.57

119.33

1.5

1.2

89.86

88.46

u/l

0.05

166

263

Other septicaemia, including avohilmo

363

888

3.88

118.91

1.3

1.2

134.53

89.50

u/l

2.71

328

728

Acute renal failure

246

482

5.20

118.22

1.3

1.2

129.04

89.04

u/l

3.14

224

388

Caries of dentine

257

499

5.05

118.12

1.4

1.2

110.82

94.56

u/l

0.96

230

415

Explicit Sepsis, including avohilmo

413

1072

3.53

116.73

1.3

1.2

131.23

86.53

u/l

3.26

372

908

L04AX Other immunosuppressants

491

1597

3.10

115.72

1.3

78.89

94.27

u/l

2.36

430

1366

Other septicaemia

353

870

3.87

115.35

1.3

1.2

134.78

89.96

u/l

2.59

319

712

Implicit bacterial Sepsis, including avohilmo

426

1033

3.47

114.38

1.4

1.2

122.02

87.07

u/l

4.30

381

872

Explicit Sepsis

402

1048

3.53

113.85

1.3

1.2

132.86

86.69

u/l

3.30

362

888

Persons encountering health services for specific procedures and health care

756

1720

2.61

113.27

1.4

1.2

102.18

89.66

u/l

1.35

672

1457

Disorders resulting from impaired renal tubular function

101

14.81

110.95

1.5

1.2

117.70

91.33

u/l

0.26

Unspecified kidney failure

154

204

7.76

109.55

1.3

127.89

94.44

u/l

0.58

131

170

Polyarthropathies

547

1173

3.02

109.23

1.3

92.04

99.97

u/l

0.85

473

1001

Reimbursement for rheumatic diseases

486

1651

2.95

104.97

1.3

1.2

97.40

90.42

u/l

0.56

435

1400

Fever of other and unknown origin

441

1212

3.18

104.60

1.4

1.2

105.78

85.43

u/l

2.99

400

1027

Used for control exclusion in common control thyroid runs

656

1207

2.76

103.49

1.3

1.2

95.66

95.51

u/l

0.01

578

1017

Dialysis

14.91

103.02

1.5

1.2

89.06

93.90

u/l

0.08

Aplastic and other anaemias

419

1211

3.20

101.74

1.3

1.2

124.27

92.00

u/l

2.18

369

1019

Ulcerative colitis

255

586

4.42

101.07

1.4

1.2

83.80

89.00

u/l

0.30

213

495

Metabolic disorders

674

1567

2.60

100.57

1.3

1.2

96.29

92.79

u/l

0.28

577

1342

Abnormal serum enzyme levels

278

661

4.12

99.37

1.3

118.15

101.61

u/l

1.26

241

546

Crohn disease

166

266

6.38

98.95

1.4

1.2

82.50

88.49

u/l

0.24

139

218

Other anaemias

395

1154

3.24

98.41

1.3

1.2

123.97

91.96

u/l

2.00

348

970

Implicit Sepsis

576

1583

2.70

98.13

1.3

1.2

116.07

85.43

u/l

4.83

508

1343

Other and unspecified anaemias

391

1147

3.24

97.31

1.3

1.2

124.30

92.11

u/l

1.98

344

964

Oral corticosteroids

692

1616

2.52

97.09

1.3

1.2

98.31

93.30

u/l

0.44

595

1394

Any gastric operation

448

673

3.36

97.01

1.2

100.36

69.95

u/l

4.71

392

541

GASTRO-related operations

448

673

3.36

97.01

1.2

100.36

69.95

u/l

4.71

392

541

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

203

404

5.12

95.96

1.5

1.2

82.71

91.79

u/l

0.49

170

343

Other Crohn's disease

109

113

9.96

94.34

1.4

1.2

78.16

74.08

u/l

0.15

Ulcerative colitis (strict definition, require KELA)

193

375

5.25

93.79

1.5

1.2

83.24

93.42

u/l

0.53

161

316

Pneumonias (Asthma/COPD co-morbidities)

698

1883

2.43

93.68

1.3

1.2

111.98

85.36

u/l

5.11

618

1607

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

189

361

5.34

93.64

1.5

1.2

83.67

91.81

u/l

0.39

158

303

All pneumoniae

701

1889

2.42

93.12

1.3

1.2

111.92

85.27

u/l

5.16

621

1612

Cholangitis (primary sclerosing, PSC)

112

123

9.45

92.96

1.3

1.2

148.47

76.80

u/l

3.34

102

100

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

183

343

5.46

92.68

1.3

1.2

151.02

88.77

u/l

4.74

169

278

Osteopathies and chondropathies

475

1556

2.82

92.29

1.4

1.2

95.24

89.60

u/l

0.45

415

1323

Heart failure,strict

404

889

3.20

91.12

1.3

1.2

123.08

86.03

u/l

6.05

354

736

Implicit Sepsis, including avohilmo

593

1659

2.57

91.11

1.3

1.2

114.09

84.08

u/l

4.86

520

1411

Secondary hypertension

109

117

9.42

90.12

1.4

1.1

84.82

81.65

u/l

0.08

Insulin, fast-acting

310

896

3.50

88.82

1.3

1.2

123.70

86.98

u/l

4.69

281

746

Influenza and pneumonia

707

1849

2.37

88.40

1.3

1.2

109.94

85.34

u/l

4.48

627

1575

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

667

1748

2.42

88.01

1.3

1.2

103.21

88.95

u/l

1.04

583

1486

Insulin, intermediate and long-acting

425

1433

2.89

87.65

1.3

1.2

119.19

91.17

u/l

3.97

383

1216

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

609

1666

2.48

85.91

1.3

1.2

112.83

83.52

u/l

4.80

537

1415

Pneumonia, organism unspecified

628

1776

2.44

85.75

1.3

1.2

112.04

86.19

u/l

4.59

557

1510

Insulin, combination of fast acting with intermediate-acting or long-acting

463

1553

2.72

84.60

1.3

1.2

121.88

91.44

u/l

4.32

415

1319

Any reimbursement code in KELA

285

336

4.27

84.37

1.2

1.1

97.74

82.35

u/l

0.97

252

279

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

671

1908

2.35

84.28

1.3

1.2

111.78

85.79

u/l

4.71

595

1627

Diabetic nephropathy, excluding more controls

188

301

5.21

83.92

1.4

1.2

116.96

99.34

u/l

0.97

174

251

Nonalcoholic fatty liver disease

148

250

6.09

83.86

1.2

102.20

88.55

u/l

0.41

133

205

616

1459

2.48

83.54

1.3

1.2

109.01

84.10

u/l

4.38

545

1238

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

616

1459

2.48

83.54

1.3

1.2

109.01

84.10

u/l

4.38

545

1238

Insulin, fast-acting or short human

312

946

3.33

82.93

1.4

1.2

123.53

90.87

u/l

3.77

283

785

Condition for Implicit Sepsis (Organ dysfunction codes)

589

1662

2.47

82.84

1.3

1.2

114.01

84.17

u/l

4.76

517

1414

Disorders of parathyroid gland

236

593

4.00

81.65

1.3

1.2

70.00

89.51

u/l

2.73

204

495

Cholangitis (primary sclerosing, PSC), with reimbursement 202

21.06

80.68

1.3

1.2

165.82

63.04

u/l

2.64

Type 1 diabetes

224

553

4.10

80.62

1.3

122.77

87.30

u/l

3.14

206

460

Nutritional anaemias

410

1402

2.81

80.43

1.3

1.2

117.76

88.97

u/l

1.83

365

1179

Insulin medication

463

1449

2.67

79.78

1.3

121.88

88.88

u/l

4.95

415

1227

Other disorders of kidney and ureter

159

307

5.30

77.99

1.4

1.2

100.64

92.67

u/l

0.11

139

257

Diabetic nephropathy

191

427

4.52

77.18

1.4

1.2

118.37

102.97

u/l

0.85

177

366

Hyperparathyroidism

212

517

4.13

76.56

1.3

1.2

67.33

90.31

u/l

3.50

183

433

Type 1 diabetes, wide definition, subgroup 1

188

423

4.50

76.50

1.4

1.2

123.76

82.79

u/l

3.45

176

351

Crohn's disease NAS

109

8.98

76.16

1.4

1.2

72.39

74.87

u/l

0.09

Disorders of gallbladder, biliary tract and pancreas

662

1818

2.28

75.95

1.3

1.2

114.54

87.56

u/l

4.89

579

1547

Ulcerative colitis, NAS

153

293

5.32

75.66

1.3

1.2

84.65

84.28

u/l

0.01

129

241

Heart failure and antihypertensive medication

215

313

4.52

75.52

1.2

1.3

129.81

105.64

u/l

1.18

191

266

Malaise and fatigue

385

1064

2.87

74.96

1.2

100.98

85.43

u/l

1.96

336

898

Diseases of arteries, arterioles and capillaries (FINNGEN)

211

333

4.42

74.09

1.3

1.2

98.57

90.39

u/l

0.38

183

284

Implicit viral Sepsis, including avohilmo

258

756

3.44

72.27

1.3

1.2

111.67

85.54

u/l

2.60

226

626

Heart failure, strict

432

1125

2.69

72.13

1.3

123.38

88.20

u/l

6.28

375

947

Iron deficiency anaemia

352

1218

2.86

71.81

1.3

1.2

122.83

88.02

u/l

2.02

316

1027

Certain infectious and parasitic diseases

569

1171

2.45

71.59

1.3

1.2

95.82

82.40

u/l

1.71

491

980

Infections, IBD-co-morbidities

139

156

6.34

71.48

1.4

1.3

111.25

106.76

u/l

0.11

118

137

Other and unspecified iron deficiency

294

943

3.15

71.11

1.3

1.2

123.54

88.22

u/l

1.63

263

788

Acute tubulo-interstitial nephritis

428

1405

2.59

69.71

1.3

1.2

117.77

85.09

u/l

2.27

377

1181

Autoimmune hepatitis, wide definition

10.79

69.50

1.3

1.1

105.31

77.81

u/l

1.18

General symptoms and signs

628

1379

2.29

68.78

1.3

1.2

100.12

83.79

u/l

2.25

547

1174

Erysipelas, including avohilmo

480

1454

2.46

68.30

1.3

1.2

109.27

85.46

u/l

3.38

412

1216

Type 1 diabetes, wide definition

188

463

4.11

68.01

1.4

1.2

123.76

87.96

u/l

2.74

176

386

Diseases of oesophagus, stomach and duodenum

667

1817

2.18

67.95

1.3

1.2

97.75

92.03

u/l

0.51

571

1566

Other heart diseases

305

626

3.19

67.22

1.3

1.2

109.56

92.69

u/l

0.78

270

542

Other dialysis

12.20

65.87

1.5

1.2

87.47

94.86

u/l

0.19

Hypertensive diseases (excluding secondary)

326

619

3.08

65.68

1.3

1.2

93.07

86.68

u/l

0.34

282

534

Intestinal infectious diseases

611

2108

2.16

64.99

1.3

1.2

103.01

91.16

u/l

1.36

537

1803

Erysipelas

381

1257

2.63

64.49

1.3

1.2

111.05

87.98

u/l

2.76

332

1046

All-cause Heart Failure

412

1111

2.60

64.47

1.3

123.03

88.51

u/l

5.83

357

934

Diseases of arteries, arterioles and capillaries

472

1442

2.42

64.45

1.3

1.2

109.95

92.61

u/l

1.94

411

1227

Other disorders of skin and subcutaneous tissue

514

1914

2.28

63.63

1.3

1.2

102.02

92.67

u/l

0.88

438

1651

Exposure to unspecified factor

649

2101

2.11

63.43

1.3

1.2

86.97

97.69

u/l

1.52

553

1816

Ulcerative colitis (strict definition, all Crohn cases excluded)

142

299

4.83

62.96

1.4

1.2

76.82

92.20

u/l

0.85

120

251

Other diseases of intestines

626

1610

2.18

62.74

1.3

1.2

100.78

89.47

u/l

1.08

538

1383

Disorders of other endocrine glands

342

1257

2.70

62.70

1.3

1.2

87.89

91.50

u/l

0.11

300

1065

Sub-endpoint used in defining T1D endpoints

227

665

3.39

62.05

1.3

1.2

120.49

98.29

u/l

1.48

209

550

Insulin, fast-acting (human)

130

257

5.14

62.03

1.4

1.1

132.69

89.11

u/l

2.63

121

211

Persons encountering health services for other counselling and medical advice, not elsewhere classified

687

1753

2.09

61.62

1.3

1.2

100.36

90.87

u/l

1.01

601

1499

Other inflammatory liver diseases

125

7.41

61.54

1.3

1.1

127.02

75.70

u/l

1.83

102

Gout, FINNGEN

224

669

3.36

60.49

1.3

109.45

106.44

u/l

0.14

191

554

Implicit viral Sepsis

184

488

3.82

60.24

1.3

1.2

104.46

87.85

u/l

1.16

162

396

Viral Sepsis

184

488

3.82

60.24

1.3

1.2

104.46

87.85

u/l

1.16

162

396

Complications of surgical and medical care, not elsewhere classified

633

2033

2.09

59.86

1.3

1.2

100.41

92.25

u/l

0.92

557

1741

Adjustment and management of implanted device

163

400

4.13

59.48

1.3

1.2

113.37

96.85

u/l

1.02

147

335

Disorders of lipoprotein metabolism and other lipidaemias

531

1443

2.25

58.98

1.2

89.29

93.06

u/l

0.32

450

1237

Diarrhoea and gastroenteritis of presumed infectious origin

457

1785

2.30

58.40

1.3

1.2

99.14

89.78

u/l

0.82

400

1511

Opioids

547

1269

2.24

57.31

1.3

1.2

94.13

87.43

u/l

0.56

468

1090

Intestinal infectious diseases, including avohilmo, including avohilmo

697

1942

2.01

56.88

1.3

1.2

99.54

91.67

u/l

0.92

612

1660

Colitis, primary sclerosing

20.70

56.80

1.3

131.44

79.00

u/l

1.35

Crohn's disease of large intestine

8.47

56.68

1.4

1.2

86.00

71.79

u/l

0.43

Gout

224

591

3.29

56.22

1.3

109.45

107.45

u/l

0.08

191

490

Pain in limb

517

1490

2.22

56.13

1.2

1.3

94.17

97.84

u/l

0.29

438

1281

Gastrointestinal diseases

289

468

3.11

56.13

1.2

99.62

71.89

u/l

2.79

252

393

Hypertensive diseases

456

1089

2.37

56.04

1.3

95.28

92.94

u/l

0.13

387

943

Hypertension

456

1089

2.37

56.02

1.3

95.28

92.94

u/l

0.13

387

943

Malignant neoplasm

509

1342

2.23

55.08

1.3

1.2

106.30

87.99

u/l

1.04

444

1144

Other disorders of fluid, electrolyte and acid-base balance

244

769

3.02

54.41

1.3

110.86

89.32

u/l

1.61

219

649

Malignant neoplasm

507

1345

2.22

54.09

1.3

1.2

106.41

87.89

u/l

1.06

442

1147

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

131

6.73

54.02

1.3

1.2

73.31

79.10

u/l

0.18

113

Hypertension, essential

443

1068

2.36

53.66

1.3

92.43

93.13

u/l

0.04

374

924

Codeine

512

1254

2.22

53.31

1.2

89.41

88.01

u/l

0.10

434

1076

Persons encountering health services for specific procedures, not carried out

143

6.34

53.01

1.4

1.2

102.71

91.21

u/l

0.30

116

Osteoporosis

249

786

2.95

52.80

1.3

1.2

98.47

86.41

u/l

0.74

212

673

Covid-19 confirmed case

277

1017

2.74

52.67

1.3

1.2

103.74

91.73

u/l

0.99

245

852

Crohn disease (strict definition, require KELA, min 2 HDR)

119

6.98

52.64

1.3

1.2

74.15

81.09

u/l

0.21

102

Crohn disease (strict definition, require KELA)

121

6.86

51.83

1.3

1.2

74.15

80.25

u/l

0.18

104

Malignant neoplasm of breast, HER2-negative

325

799

2.65

51.70

1.2

73.52

78.45

u/l

0.35

291

692

Malignant neoplasm of breast

325

799

2.65

51.67

1.2

73.52

78.45

u/l

0.35

291

692

Personal history of malignant neoplasm

111

227

5.01

51.15

1.2

89.97

77.05

u/l

0.36

196

Malignant neoplasm of breast, HER-positive

272

723

2.83

50.98

1.2

75.36

77.95

u/l

0.14

247

625

Unspecified privation

109

220

5.05

50.91

1.2

104.90

85.84

u/l

0.78

185

Malignant neoplasm of breast, HER2-negative, including Hilmo

326

804

2.62

50.77

1.2

73.98

78.79

u/l

0.34

293

697

Malignant neoplasm of breast, including Hilmo

326

804

2.62

50.76

1.2

73.98

78.79

u/l

0.34

293

697

Malignant neoplasm of breast, ER-positive, including Hilmo

272

724

2.82

50.73

1.2

75.36

77.96

u/l

0.14

247

626

Chronic hepatitis, not elsewhere classified

9.90

50.67

1.4

1.1

103.54

79.81

u/l

0.55

Asthma, unspecified (mode), excluding more controls

313

858

2.62

50.60

1.3

1.2

102.56

75.26

u/l

2.95

270

726

Peripheral artery disease

306

929

2.62

50.52

1.3

1.2

116.07

95.75

u/l

1.93

274

774

Gout, idiopatic and unspecified

192

589

3.30

50.42

1.3

109.26

103.12

u/l

0.29

167

481

Crohn's disease of small intestine

125

6.63

50.24

1.6

1.2

76.06

76.19

u/l

0.00

106

Gout, strict definition

155

416

3.78

50.01

1.2

1.3

107.05

104.79

u/l

0.08

136

336

Malignant neoplasm, including Hilmo

500

1355

2.16

49.96

1.3

1.2

103.93

88.28

u/l

0.83

436

1156

Certain disorders involving the immune mechanism

172

496

3.52

49.87

1.3

1.2

115.86

92.45

u/l

0.97

156

416

Oedema, not elsewhere classified

239

817

2.88

49.63

1.3

1.2

101.43

84.17

u/l

1.49

204

683

Malignant neoplasm, wide definition

498

1360

2.14

48.76

1.3

1.2

104.16

88.19

u/l

0.84

433

1161

Other arthritis (FG)

234

821

2.88

48.69

1.2

1.3

89.33

88.31

u/l

0.05

204

685

Heart failure and bmi 25plus

243

550

2.97

48.21

1.2

121.26

84.39

u/l

4.26

209

477

Complications of procedures, not elsewhere classified

504

1982

2.06

48.04

1.3

1.2

98.96

92.69

u/l

0.62

443

1695

Endocrine, nutritional and metabolic diseases

402

858

2.37

48.00

1.2

89.20

89.06

u/l

0.01

351

725

Pure hypercholesterolaemia

464

1371

2.16

47.46

1.2

94.47

92.57

u/l

0.13

397

1172

Cardiovascular diseases (excluding rheumatic etc)

324

723

2.57

47.44

1.3

1.2

95.61

89.82

u/l

0.25

288

626

Solid cancers

479

1316

2.14

47.15

1.3

1.2

100.42

88.01

u/l

0.59

413

1124

Codes for special purposes

351

1507

2.32

47.10

1.3

1.2

104.18

90.32

u/l

1.44

312

1280

Persons encountering health services in other circumstances, wide

656

1757

1.93

46.91

1.3

1.2

100.19

90.81

u/l

1.03

564

1503

Other heart diseases, wide

522

1539

2.06

46.89

1.3

1.2

100.63

89.17

u/l

1.01

462

1324

Peripheral artery operations in Hilmo

117

269

4.41

46.59

1.4

1.2

128.09

97.76

u/l

1.41

110

223

Provisional assignment of new diseases of uncertain etiology

349

1507

2.31

46.23

1.3

1.2

104.08

90.41

u/l

1.40

310

1280

Bleeding

517

1798

2.03

45.88

1.3

1.2

107.28

91.09

u/l

2.18

454

1531

Diseases of the digestive system

318

1327

2.39

45.71

1.3

1.2

109.97

93.95

u/l

1.69

288

1120

Care involving use of rehabilitation procedures

387

1581

2.21

45.43

1.3

1.2

89.49

90.52

u/l

0.05

340

1339

Gout, unspecified

162

480

3.42

45.05

1.3

107.86

104.68

u/l

0.13

143

384

Pain, not elsewhere classified

199

669

3.00

44.75

1.4

1.2

102.00

82.36

u/l

1.44

182

560

Biological medication for rheuma

151

430

3.56

44.66

1.2

72.40

91.71

u/l

1.86

132

365

Other specified/unspecified arthritis

209

726

2.91

44.36

1.2

1.3

84.32

93.46

u/l

0.73

182

611

Solid cancers, including Hilmo

480

1347

2.08

44.07

1.3

1.2

102.68

88.10

u/l

0.73

414

1151

Hernia of abdominal wall, postoperative

120

291

4.13

44.02

1.3

1.2

98.31

67.80

u/l

2.51

104

233

Finngen Rheumatological endpoints

527

1492

2.01

43.77

1.2

1.3

90.49

96.27

u/l

0.50

461

1283

Asthma, unspecified (mode)

320

963

2.41

43.63

1.3

1.2

102.15

79.24

u/l

2.26

273

815

Complications of medical and surgical care

464

2067

2.03

43.41

1.3

1.2

106.80

91.76

u/l

1.73

409

1773

Hypertensive heart and/or renal disease

178

396

3.31

43.36

1.3

115.11

93.94

u/l

1.40

161

334

Other diseases of intestine

139

384

3.67

43.06

1.4

1.3

113.65

87.64

u/l

1.03

118

321

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

584

1970

1.91

42.97

1.3

1.2

96.65

92.00

u/l

0.37

514

1683

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

433

1825

2.08

42.92

1.2

107.20

91.89

u/l

1.76

371

1560

Ulcerative ileocolitis

8.83

42.77

1.2

126.67

80.92

u/l

1.57

Atherosclerosis, excluding cerebral and coronary sclerosis

276

863

2.53

42.49

1.3

111.04

94.32

u/l

1.49

247

721

Other noninfective gastroenteritis and colitis

188

633

3.00

42.17

1.3

1.2

98.43

90.49

u/l

0.35

161

532

Follow-up examination after treatment for conditions other than malignant neoplasms

268

690

2.60

41.88

1.2

85.99

87.46

u/l

0.09

231

584

Other diseases of biliary tract

202

4.79

41.82

1.4

1.2

150.54

75.95

u/l

3.70

166

Medical observation and evaluation for suspected diseases and conditions

352

768

2.35

41.46

1.3

1.2

93.53

89.76

u/l

0.21

304

653

Heart failure and coronary heart disease

294

845

2.45

41.29

1.2

1.3

132.42

92.25

u/l

5.22

258

706

Any event in cancer register

495

1445

2.01

41.23

1.3

1.2

103.76

88.82

u/l

0.78

429

1233

Other and unspecified polyneuropathies, also in other diseases

155

473

3.32

41.19

1.3

1.2

100.74

92.77

u/l

0.38

133

382

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

249

585

2.70

41.09

1.3

1.2

105.35

86.61

u/l

1.64

215

505

Sulfasalazine

194

676

2.89

40.97

1.3

1.2

83.65

87.11

u/l

0.17

175

575

Infections of the skin and subcutaneous tissue

358

1630

2.17

40.92

1.3

1.2

99.75

95.27

u/l

0.25

322

1375

Osteomyelitis

122

6.03

40.78

1.5

1.1

126.85

87.54

u/l

1.41

101

Diabetes, varying definitions

571

1752

1.90

40.34

1.3

1.2

103.14

87.34

u/l

2.10

500

1496

Hypertensive Renal Disease

9.02

40.30

1.3

1.4

101.14

99.86

u/l

0.02

Atrial fibrillation and flutter

199

429

3.01

40.22

1.3

1.2

106.80

87.37

u/l

0.93

177

368

Other soft tissue disorders, not elsewhere classified

520

1518

1.96

39.99

1.2

1.3

91.43

97.08

u/l

0.55

442

1308

Certain infectious and parasitic diseases, including avohilmo

362

797

2.28

39.77

1.2

98.49

81.00

u/l

1.58

309

667

Tumor necrosis factor alpha inhibitors

135

386

3.54

39.75

1.1

1.2

68.84

90.10

u/l

2.32

117

327

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

391

1858

2.07

39.62

1.3

1.2

100.84

92.35

u/l

0.78

343

1585

Asthma, excluding more controls

380

881

2.22

39.51

1.3

1.2

102.27

74.71

u/l

3.46

321

746

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

543

1693

1.91

39.41

1.3

108.24

88.50

u/l

2.66

481

1444

Pain in joint

332

890

2.30

39.33

1.2

82.19

96.71

u/l

1.37

289

761

Other retinal disorders

410

1514

2.07

39.25

1.3

1.2

102.37

96.04

u/l

0.49

349

1305

Chronic gastritis

203

742

2.76

39.25

1.2

108.51

91.38

u/l

0.94

173

624

Cholelithiasis, broad definition with cholecystitis

502

1729

1.94

39.17

1.3

1.2

102.45

86.69

u/l

1.92

437

1468

Polyneuropathies and other disorders of the peripheral nervous system

168

559

3.04

38.63

1.3

1.2

99.52

93.59

u/l

0.28

145

453

COPD/asthma related infections

554

1459

1.91

38.47

1.3

1.2

94.71

84.10

u/l

1.44

490

1238

COPD/asthma/ILD related infections

554

1459

1.91

38.47

1.3

1.2

94.71

84.10

u/l

1.44

490

1238

Low back pain

447

1512

2.00

38.35

1.3

92.02

95.32

u/l

0.24

393

1304

Liquid cancers

197

675

2.78

38.28

1.2

150.23

87.48

u/l

2.00

182

568

Diabetes mellitus

566

1755

1.87

38.28

1.3

103.27

87.41

u/l

2.10

495

1499

Continuous positive airway pressure

134

315

3.58

38.22

1.2

1.3

114.35

77.22

u/l

2.56

121

268

Codeine or tramadol medication

616

1844

1.82

37.83

1.2

1.3

89.60

96.24

u/l

0.70

523

1593

Ascites

180

4.82

37.66

1.4

1.2

184.09

85.91

u/l

3.65

152

Cholelithiasis

484

1715

1.93

37.66

1.2

102.07

86.50

u/l

1.81

420

1455

Cardiovascular diseases

280

601

2.48

37.41

1.3

1.2

94.37

89.89

u/l

0.16

243

516

Asthma

404

990

2.11

37.24

1.3

1.2

102.68

78.95

u/l

2.84

343

838

Bacterial pneumonia, not elsewhere classified

244

870

2.48

37.03

1.3

1.2

116.99

93.15

u/l

1.84

217

727

Disorders of choroid and retina

492

1813

1.91

36.97

1.3

1.2

100.04

94.14

u/l

0.53

418

1571

Acute peritonitis

128

5.59

36.64

1.4

1.2

94.40

86.91

u/l

0.25

106

Cardiac arrhythmias

324

930

2.24

36.62

1.3

1.2

100.39

81.47

u/l

1.43

285

796

Asthma (only as main-diagnosis), excluding more controls

350

881

2.20

36.53

1.3

1.2

100.63

74.71

u/l

2.98

310

746

L02BG Aromatase inhibitors

246

1011

2.43

36.40

1.2

70.88

85.87

u/l

1.41

223

867

Bacterial pneumoniae

253

925

2.42

36.36

1.3

1.2

130.59

92.27

u/l

1.41

226

779

Glomerulonephritis

202

4.48

36.18

1.4

1.2

85.29

95.83

u/l

0.39

168

Streptococcal septicaemia, including avohilmo

160

4.95

35.83

1.4

1.2

110.40

85.79

u/l

0.82

132

Diabetes, insulin treatment (Kela reimbursement)

575

1894

1.81

35.65

1.3

108.31

88.53

u/l

2.87

508

1614

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

7.68

35.35

1.5

1.2

105.38

67.46

u/l

1.75

Medicines for HER+ breast cancer

277

1140

2.28

35.30

1.2

75.44

85.38

u/l

0.78

251

982

Liquid cancers, including Hilmo

225

794

2.52

35.27

1.2

145.84

86.32

u/l

2.24

207

674

Other diseases of arteries and capillaries

207

4.37

35.09

1.4

1.2

108.73

82.32

u/l

1.00

174

Neoplasms

347

837

2.18

34.87

1.2

101.83

88.04

u/l

0.48

295

719

Diaphragmatic hernia

259

1125

2.32

34.84

1.2

1.3

87.91

90.65

u/l

0.13

214

956

Explicit bacterial Sepsis, including avohilmo

204

4.37

34.79

1.4

1.2

104.93

83.58

u/l

0.81

171

Type 2 diabetes, wide definition

468

1550

1.91

34.65

1.3

99.64

90.38

u/l

0.95

411

1322

Rheumatoid arthritis

225

807

2.49

34.47

1.2

82.68

93.73

u/l

1.09

201

687

Ulcerative rectosigmoiditis

143

5.12

34.36

1.4

1.1

95.43

78.98

u/l

0.58

115

Disorders of mineral metabolism

174

4.67

34.31

1.5

1.2

95.40

89.71

u/l

0.16

145

Viral pneumonia

101

263

3.89

34.16

1.4

1.2

104.94

88.75

u/l

0.73

219

Streptococcal septicaemia

157

4.85

33.66

1.5

1.2

110.91

86.39

u/l

0.77

129

GI-bleeding

214

867

2.49

33.62

1.2

106.80

96.98

u/l

0.68

193

711

Oxycodone

244

885

2.37

33.52

1.5

1.2

117.78

90.39

u/l

1.85

223

747

Spondyloarthritis

122

365

3.37

33.51

1.2

123.62

93.78

u/l

1.22

111

299

Cutaneous abscess, furuncle and carbuncle

179

667

2.71

33.42

1.3

1.2

97.02

85.33

u/l

0.69

165

563

Asthma (mode)

388

998

2.05

33.36

1.3

1.2

104.12

78.88

u/l

3.11

329

845

Hypothyroidism (congenital or acquired)

100

125

4.50

33.34

1.3

1.2

82.48

72.54

u/l

0.46

102

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

356

1776

2.01

33.32

1.4

1.2

102.51

94.22

u/l

0.67

311

1507

Haemorrhage from respiratory passages

227

831

2.43

33.25

1.3

1.2

107.39

88.91

u/l

1.69

199

696

Diabetes medication

569

1874

1.78

33.10

1.3

1.2

105.95

87.14

u/l

2.68

500

1601

Non-ischemic cardiomyopathy

210

658

2.55

33.08

1.3

109.01

87.60

u/l

1.73

181

556

Crohn disease (strict definition, all UC cases excluded)

6.13

32.87

1.3

1.2

66.53

75.99

u/l

0.33

Nausea and vomiting

188

705

2.62

32.78

1.3

1.2

125.04

89.76

u/l

1.48

163

595

Explicit bacterial Sepsis

202

4.26

32.56

1.5

1.2

105.16

83.71

u/l

0.78

169

Systemic connective tissue disorders

245

1072

2.30

32.45

1.3

1.2

88.24

88.15

u/l

0.01

213

911

Other ulcerative colitis

100

5.91

32.30

1.5

1.2

95.43

78.45

u/l

0.64

Congenital malformations of the urinary system

114

5.55

32.29

1.4

1.2

154.75

81.82

u/l

0.53

101

Diverticular disease of intestine

411

1317

1.95

32.24

1.2

86.47

92.23

u/l

0.49

352

1128

Other CVD (FINNGEN)

142

4.56

32.09

1.4

1.3

83.87

88.83

u/l

0.13

121

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

113

4.95

32.02

1.2

1.3

106.83

87.81

u/l

0.41

Diseases of the skin and subcutaneous tissue

495

1344

1.85

31.68

1.3

1.2

99.27

91.84

u/l

0.53

418

1157

105

296

3.59

31.67

1.3

1.2

83.55

82.26

u/l

0.04

245

Atrial fibrillation and flutter with reimbursement

161

344

2.97

31.65

1.2

104.65

85.51

u/l

0.83

141

297

Constipation

511

1936

1.79

31.62

1.3

1.2

96.38

94.01

u/l

0.16

442

1665

Asthma (only as main-diagnosis)

361

990

2.05

31.45

1.3

1.2

101.00

78.95

u/l

2.33

320

838

Other diseases of blood and blood-forming organs, wide

167

621

2.72

31.38

1.2

134.53

88.10

u/l

1.15

156

521

Hypothyroidism, levothyroxine purchases

125

4.37

31.32

1.3

1.2

85.33

72.54

u/l

0.61

102

Hypothyroidism and >3 levothyroxin purchases

125

4.37

31.32

1.3

1.2

85.33

72.54

u/l

0.61

102

Congenital malformations of the urinary system, including avohilmo

121

5.31

31.28

1.3

1.2

153.65

80.18

u/l

0.54

105

Pain in throat and chest

443

1394

1.89

31.22

1.2

93.40

88.02

u/l

0.44

379

1189

Other diseases of the digestive system

209

869

2.42

31.09

1.2

107.95

96.87

u/l

0.79

189

711

Pleural effusion

119

371

3.24

30.68

1.2

117.13

94.26

u/l

1.13

104

308

Alcoholic liver disease

195

4.21

30.56

1.2

157.11

89.00

u/l

2.69

159

Bacterial pneumonia (organism specified)

271

1138

2.17

30.54

1.3

1.2

127.85

94.53

u/l

1.26

241

959

Fall on same level

590

1825

1.73

30.50

1.3

1.2

101.19

92.27

u/l

0.77

500

1585

COPD differential diagnosis

393

998

1.98

30.47

1.3

1.2

95.30

78.88

u/l

2.24

344

845

ILD differential diagnosis

393

998

1.98

30.46

1.3

1.2

95.30

78.88

u/l

2.24

344

845

Excluding asthma or asthma-COPD overlap

394

1002

1.98

30.42

1.3

1.2

94.97

78.56

u/l

2.25

344

850

Gastro-oesophageal reflux disease

382

1687

1.92

30.40

1.3

1.2

90.94

92.27

u/l

0.07

324

1455

Amputation of foot

7.92

30.35

1.4

1.3

135.36

104.51

u/l

0.62

Asthma, hospital admission 2, infections

349

1747

1.96

30.21

1.3

1.2

109.10

94.36

u/l

1.10

302

1502

Asthma-related infections

349

1747

1.96

30.21

1.3

1.2

109.10

94.36

u/l

1.10

302

1502

Cardiomyopathy

115

355

3.27

30.07

1.2

1.3

108.33

89.05

u/l

1.10

100

291

Type 2 diabetes

520

1702

1.77

29.99

1.3

97.15

87.91

u/l

1.11

451

1451

Diabetic retinopathy, excluding more controls

190

401

2.68

29.84

1.4

1.2

109.05

97.24

u/l

0.65

169

338

Fracture of femur

187

674

2.52

29.64

1.3

1.2

98.80

91.41

u/l

0.30

166

558

Other pulmonary diagnosis

391

1002

1.96

29.57

1.3

1.2

94.53

78.56

u/l

2.14

342

850

Abnormalities of breathing

452

1405

1.85

29.56

1.3

1.2

105.78

88.96

u/l

1.72

389

1198

Disorder of lipoprotein metabolism, unspecified

277

3.58

29.49

1.4

1.2

93.23

93.65

u/l

0.01

228

Adalimumab

205

4.05

29.43

1.1

1.2

67.35

88.69

u/l

1.80

170

Benign neoplasm of colon, rectum, anus and anal canal

386

1738

1.89

29.24

1.2

112.38

92.14

u/l

1.74

324

1492

Disorders of thyroid, IBD co-morbidities

176

3.83

29.12

1.2

1.3

81.47

101.22

u/l

0.82

155

Polycystic kidney disease

7.73

29.03

1.3

1.1

85.74

79.76

u/l

0.21

Lower back pain or/and sciatica

575

2111

1.70

28.92

1.3

1.2

91.97

93.66

u/l

0.13

500

1814

UC patients in KELA-register (code 208), prior to 1994

6.01

28.79

1.5

1.2

84.19

86.37

u/l

0.05

Other disorders of urethra and urinary system

391

1450

1.88

28.43

1.2

91.23

91.86

u/l

0.03

334

1246

Other gastritis (incl. Duodenitis)

152

568

2.70

28.33

1.3

1.2

120.33

90.33

u/l

1.49

129

474

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

160

4.45

28.29

1.4

1.2

125.65

81.02

u/l

1.64

131

Paralytic ileus and intestinal obstruction

168

660

2.56

28.23

1.4

1.2

114.99

88.85

u/l

1.47

152

551

Asthma-related pneumonia or sepsis

240

1100

2.19

28.20

1.3

1.2

112.65

93.79

u/l

1.26

206

932

Asthma, hospital admissions 3, pneumonia

240

1100

2.19

28.20

1.3

1.2

112.65

93.79

u/l

1.26

206

932

Asthma-related pneumonia

239

1097

2.18

27.99

1.3

1.2

112.87

93.79

u/l

1.27

205

930

Cerebrovascular diseases (FINNGEN)

171

458

2.63

27.96

1.3

1.2

114.38

86.93

u/l

1.27

144

395

Chronic pancreatitis

278

3.50

27.88

1.4

1.2

152.64

81.61

u/l

2.92

229

Other diseases of urinary system

510

1645

1.75

27.70

1.3

1.2

101.07

94.58

u/l

0.46

432

1424

Abnormal results of function studies

189

4.08

27.51

1.3

1.1

123.50

78.74

u/l

2.07

158

Other specific joint derangements/joint disorders

376

1237

1.90

27.47

1.3

86.73

98.57

u/l

0.95

325

1055

Statin medication

337

956

1.99

27.47

1.2

1.3

106.28

92.27

u/l

0.82

289

842

Collagenous colitis

203

3.95

27.35

1.3

1.2

104.68

80.24

u/l

1.15

169

Other diseases of pancreas

186

4.10

27.27

1.4

1.3

113.02

78.65

u/l

1.86

159

Other bacterial intestinal infections

128

448

2.88

27.04

1.4

1.2

110.53

92.26

u/l

0.92

111

375

Noninfectious colitis NAS

299

3.35

26.92

1.3

1.2

95.69

83.86

u/l

0.39

246

Cystic kidney disease

6.24

26.86

1.3

1.2

176.82

80.15

u/l

0.51

Dyspnoea

491

2066

1.72

26.76

1.3

1.2

107.32

91.50

u/l

1.85

429

1771

Seropositive rheumatoid arthritis

170

689

2.47

26.51

1.2

81.75

86.99

u/l

0.37

154

583

Cystic kidney disease, including avohilmo

6.15

26.50

1.3

1.2

176.82

80.25

u/l

0.51

Antihypertensive medication - note that there are other indications

260

624

2.18

26.34

1.2

1.3

96.97

89.35

u/l

0.33

226

536

Disorders of lens

392

1323

1.85

26.15

1.3

1.2

105.19

89.81

u/l

1.42

345

1129

Other systemic involvement of connective tissue (FG)

171

690

2.45

26.10

1.3

1.2

88.95

90.06

u/l

0.05

148

583

Viral pneumonia (unknown virus, not influenza)

126

4.76

25.94

1.3

1.2

118.71

91.10

u/l

0.91

110

Benign neoplasm: Colon

329

1639

1.89

25.74

1.3

1.2

111.94

93.65

u/l

1.32

277

1400

Speech therapy

181

770

2.37

25.73

1.2

90.93

89.54

u/l

0.05

150

646

Diseases of peritoneum

236

3.61

25.59

1.4

1.2

95.05

88.27

u/l

0.24

195

Artificial opening status

105

5.14

25.47

1.4

1.2

148.02

89.62

u/l

1.03

Asthma (diagnoses ohter than nonallergic)

469

2225

1.71

25.43

1.3

1.2

100.11

91.52

u/l

0.72

395

1927

Hypothyroidism, drug reimbursement

4.68

25.30

1.2

90.92

74.36

u/l

0.72

All influenza

155

620

2.52

25.17

1.4

1.2

96.83

92.44

u/l

0.20

143

508

Rheumatoid arthritis, including avohilmo

243

1176

2.08

25.14

1.2

83.38

90.49

u/l

0.64

215

997

Cystitis

443

1503

1.76

25.08

1.2

95.23

92.01

u/l

0.20

380

1294

Other functional intestinal disorders

258

1159

2.03

24.69

1.3

1.2

102.18

88.94

u/l

1.13

227

993

Spondylopathies

420

1401

1.78

24.68

1.2

91.32

98.40

u/l

0.58

359

1204

Other or unspecified ileus, impaction or obstruction

120

427

2.83

24.60

1.5

1.2

122.24

93.10

u/l

1.18

107

350

Hypertensive Heart Disease

134

372

2.75

24.38

1.3

118.69

92.79

u/l

1.51

122

314

Viral and other specified intestinal infections

110

365

2.96

24.35

1.4

1.2

156.52

81.84

u/l

1.28

104

306

Valvular heart disease excluding rheumatic fever

255

888

2.06

24.15

1.3

1.2

117.08

85.86

u/l

2.80

220

752

Cardiomyopathy, other and unspecified

142

4.36

24.12

1.2

110.54

90.34

u/l

0.68

116

Bacterial intestinal infections, IBD co-morbidities

128

477

2.71

24.08

1.4

1.2

109.59

94.47

u/l

0.72

111

399

Non-rheumatic valve diseases

254

884

2.06

24.05

1.3

1.2

111.38

85.66

u/l

2.85

219

748

Cholecystectomy

403

1965

1.75

23.98

1.3

1.2

91.61

94.58

u/l

0.24

350

1681

Other nutritional deficiencies

363

1853

1.80

23.97

1.3

83.35

91.79

u/l

1.05

315

1586

Depression

501

2019

1.66

23.86

1.3

99.51

89.03

u/l

1.05

439

1725

Viral and other specified intestinal infections, including avohilmo

147

566

2.51

23.69

1.3

1.2

144.43

83.99

u/l

1.38

137

478

Type 1 diabetes, definitions combined

148

4.22

23.59

1.4

1.2

133.25

87.70

u/l

1.31

126

Fungal Sepsis

5.54

23.42

1.6

1.2

139.72

78.10

u/l

2.97

Vitreous haemorrhage

236

3.48

23.39

1.5

1.2

112.39

87.93

u/l

1.27

195

Dorsalgia

490

1544

1.69

23.35

1.2

1.3

87.08

95.45

u/l

0.92

417

1334

Fracture of lumbar spine and pelvis

149

608

2.46

23.14

1.3

1.2

93.76

91.67

u/l

0.08

135

501

Primary_lymphoid and hematopoietic malignant neoplasms

154

640

2.43

23.12

1.2

159.80

98.26

u/l

1.36

143

523

Symptoms and signs involving the digestive system and abdomen

478

1415

1.70

23.04

1.3

1.2

101.63

90.82

u/l

0.81

409

1203

Other bacterial intestinal infections, including avohilmo

150

618

2.44

22.95

1.3

1.2

110.83

89.54

u/l

1.28

127

514

Other diseases of pleura

257

1130

1.99

22.94

1.3

1.2

127.06

95.62

u/l

2.74

228

950

Nephrotic syndrome

6.26

22.93

1.3

1.2

81.48

89.49

u/l

0.19

Type 1 diabetes, strict (exclude DM2)

152

4.11

22.79

1.4

1.2

133.25

100.77

u/l

0.70

130

Mood disorders

529

2090

1.62

22.69

1.2

1.3

98.97

90.15

u/l

0.86

463

1791

Dermatitis and eczema

575

2141

1.59

22.58

1.3

1.2

94.70

93.63

u/l

0.07

491

1853

Cellulitis

141

569

2.50

22.57

1.4

1.2

102.98

86.74

u/l

1.01

130

476

Abdominal and pelvic pain

475

1415

1.69

22.57

1.2

96.63

90.82

u/l

0.37

409

1203

Hyperlipidaemia, other/unspecified

218

942

2.09

22.54

1.3

97.27

91.88

u/l

0.27

185

803

Mood disorders, excluding more controls

484

1714

1.66

22.51

1.2

1.3

98.95

90.63

u/l

0.76

422

1483

Peripheral arterial reconstruction

112

404

2.80

22.46

1.3

106.33

102.00

u/l

0.14

333

Mood [affective] disorders

527

2090

1.62

22.43

1.2

1.3

98.79

90.15

u/l

0.83

461

1791

Use of hypnotics and sedatives

538

1903

1.62

22.40

1.3

1.2

96.64

94.52

u/l

0.15

456

1646

Gastroduodenal ulcer

154

647

2.39

22.39

1.2

1.3

113.06

97.37

u/l

0.73

135

537

Arthropathies in other diseases classified elsewhere

6.56

22.25

1.4

1.2

124.16

85.41

u/l

1.16

L04AC Interleukin inhibitors

126

4.43

22.23

1.1

78.62

88.10

u/l

0.31

105

Injuries to the hip and thigh

282

1340

1.89

22.09

1.3

1.2

98.26

93.70

u/l

0.24

248

1136

250

1270

1.96

22.09

1.4

1.2

109.54

92.63

u/l

1.01

224

1083

Injuries to the abdomen, lower back, lumbar spine and pelvis

239

1188

1.99

22.05

1.3

1.2

92.64

92.11

u/l

0.02

211

995

Gingival hyperplasia

5.59

22.03

1.4

1.2

111.97

73.96

u/l

1.14

Diabetic retinopathy, strict definition

126

428

2.64

22.00

1.4

1.2

118.27

105.75

u/l

0.55

118

369

Paroxysmal tachycardia

117

357

2.74

21.69

1.5

1.2

99.17

86.99

u/l

0.54

105

306

ILD, hospital admission 2, with pulmonary infections

195

3.63

21.65

1.1

1.2

120.16

90.75

u/l

0.68

157

Coagulation defects, purpura and other haemorrhagic conditions

128

505

2.56

21.52

1.3

1.2

121.15

93.13

u/l

1.08

123

426

Intestinal stricture

193

910

2.13

21.48

1.4

1.2

110.26

92.56

u/l

0.96

170

750

Presence of cardiac and vascular implants and grafts

238

874

2.01

21.37

1.3

119.59

93.15

u/l

2.70

211

726

Urinary track infection

322

866

1.87

21.37

1.3

1.2

87.54

84.65

u/l

0.16

281

760

Anxiety disorders, excluding more controls

427

1621

1.69

21.35

1.2

1.3

91.59

88.33

u/l

0.22

367

1396

L02BA Anti-estrogens

129

514

2.54

21.29

1.2

82.22

79.51

u/l

0.08

120

438

Idiopathic gout

188

3.66

21.28

1.3

115.23

100.14

u/l

0.41

155

Hypokalaemia

287

3.10

21.19

1.3

1.2

88.60

92.62

u/l

0.15

237

Gingivitis and periodontal diseases

494

1560

1.64

21.14

1.3

1.2

102.65

98.67

u/l

0.15

420

1333

Symptoms and signs involving cognition, perception, emotional state and behaviour

497

2064

1.61

21.05

1.2

1.3

94.90

94.54

u/l

0.02

421

1785

Benign neoplasm of other and ill-defined parts of digestive system

127

505

2.54

21.05

1.3

1.2

95.72

91.83

u/l

0.18

115

423

Anxiety (asthma-related co-morbidities)

313

1313

1.82

20.95

1.2

1.3

91.79

86.58

u/l

0.28

268

1120

Other systemic involvement of connective tissue

178

824

2.18

20.79

1.3

1.2

88.63

87.92

u/l

0.03

155

701

Diabetic maculopathy, excluding more controls

210

3.46

20.78

1.4

1.2

120.32

93.94

u/l

1.13

174

Implicit fungal Sepsis, including avohilmo

142

4.07

20.67

1.5

1.2

112.58

74.24

u/l

2.13

121

Implicit fungal Sepsis

5.37

20.66

1.6

1.2

131.39

78.31

u/l

2.58

Total colectomy

5.23

20.57

1.7

1.2

85.94

78.13

u/l

0.22

Total colectomy operation

5.23

20.57

1.7

1.2

85.94

78.13

u/l

0.22

Headache

307

1310

1.82

20.56

1.3

1.2

85.83

83.53

u/l

0.15

263

1114

Symptoms and signs involving the circulatory and respiratory systems

464

1410

1.65

20.37

1.3

1.2

94.62

88.73

u/l

0.53

404

1203

Parasetamol

321

885

1.84

20.35

1.2

104.69

92.27

u/l

0.75

271

773

Enterocolitis due to Clostridium difficile

243

3.24

20.29

1.4

1.2

111.06

95.45

u/l

0.53

201

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

496

1961

1.60

20.27

1.3

1.2

98.74

95.20

u/l

0.31

429

1676

Dermatitis

340

1925

1.73

20.22

1.3

1.2

96.03

94.02

u/l

0.11

281

1667

Other infectious diseases

167

3.76

20.18

1.2

111.50

91.18

u/l

0.69

140

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

115

4.41

20.13

1.1

1.2

209.16

87.95

u/l

2.68

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

142

280

2.55

20.03

1.2

89.88

70.29

u/l

1.24

123

233

Depression medications

133

3.37

19.97

1.2

98.76

69.24

u/l

1.34

110

Ulcerative proctitis

104

4.58

19.86

1.6

1.2

66.68

79.30

u/l

0.70

Hypo-osmolality and hyponatraemia

111

422

2.63

19.81

1.2

120.36

90.14

u/l

1.20

103

348

Cardiomyopathy (excluding other)

237

3.24

19.74

1.2

125.25

89.68

u/l

1.77

191

563

1835

1.56

19.55

1.3

1.2

100.42

88.90

u/l

1.28

500

1568

Other CVD

128

530

2.43

19.46

1.4

1.2

85.79

96.92

u/l

0.62

110

437

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

464

2268

1.60

19.43

1.2

1.3

90.14

94.12

u/l

0.30

396

1955

Hypothyroidism, strict autoimmune

303

1103

1.81

19.40

1.2

85.44

91.13

u/l

0.47

267

921

Primary hyperparathyroidism

319

2.89

19.37

1.2

70.10

84.78

u/l

0.96

270

Other diseases of stomach and duodenum

145

3.92

19.30

1.3

1.1

125.35

79.12

u/l

0.98

123

Periodontitis

509

2069

1.57

19.24

1.3

1.2

92.96

94.01

u/l

0.06

437

1777

Neurotic, stress-related and somatoform disorders

453

1943

1.61

19.22

1.2

1.3

92.71

89.88

u/l

0.19

391

1669

ILD, hospital admissions 3, with pneumonia sepsis

173

3.63

19.18

1.1

1.3

128.77

92.15

u/l

0.79

144

Syncope and collapse

221

942

1.97

19.17

1.3

1.2

110.03

86.57

u/l

1.67

187

794

Other/unspecified dorsalgia

210

1052

1.98

19.15

1.2

1.3

85.39

94.37

u/l

0.65

174

892

Cough

228

1107

1.93

19.11

1.2

86.87

87.95

u/l

0.05

205

945

Methotrexate

321

2.86

19.11

1.2

77.59

86.40

u/l

0.48

275

Anxiety disorders

457

1959

1.60

19.10

1.2

1.3

92.13

90.31

u/l

0.11

395

1682

Other necrotizing vasculopathies

160

3.74

19.05

1.4

1.2

85.66

85.67

u/l

0.00

136

Diabetic retinopathy

222

692

2.00

18.99

1.4

1.2

109.06

105.70

u/l

0.16

195

601

All anxiety disorders

316

1401

1.76

18.97

1.2

1.3

91.42

88.66

u/l

0.13

270

1198

Other respiratory diseases principally affecting the interstitium

113

447

2.55

18.97

1.1

1.2

117.19

95.23

u/l

0.73

363

Chronic tubulo-interstitial nephritis

5.31

18.95

1.3

1.2

73.27

73.18

u/l

0.00

Open wound of lower leg

100

373

2.70

18.89

1.4

1.2

121.43

94.19

u/l

0.80

314

Chronic periodontitis, including avohilmo

507

2072

1.56

18.83

1.3

1.2

93.40

93.92

u/l

0.03

435

1780

Enlarged lymph nodes

352

2.75

18.74

1.3

1.2

128.01

83.58

u/l

1.66

293

Sarcoidosis

325

2.83

18.70

1.2

114.19

89.04

u/l

0.83

270

Irritable bowel syndrome

153

697

2.21

18.64

1.2

99.62

82.32

u/l

0.69

135

598

Other infectious diseases, including avohilmo

196

3.41

18.58

1.2

108.83

91.17

u/l

0.62

163

Obesity, other/unspecified

189

936

2.03

18.52

1.2

1.3

77.43

89.97

u/l

1.60

174

794

Symptoms and signs concerning food and fluid intake

212

3.28

18.32

1.3

1.2

160.40

81.81

u/l

0.69

172

Myocardial infarction, without ST-elevation

218

1022

1.93

18.28

1.2

1.3

118.37

96.52

u/l

1.58

189

854

Other and unspecified dermatitis

285

1621

1.76

18.19

1.3

1.2

96.50

92.69

u/l

0.21

238

1389

Benzodiazepine use

501

2184

1.55

18.15

1.3

95.57

93.38

u/l

0.16

428

1886

Chronic nephritic syndrome

5.10

18.14

1.4

1.2

67.27

88.91

u/l

1.16

Cardiomyopathies, Primary/intrinsic

229

3.17

18.14

1.2

1.3

128.10

92.28

u/l

1.70

187

Obesity

326

1812

1.70

18.01

1.2

1.3

79.76

92.46

u/l

2.06

283

1549

Pain (limb, back, neck, head abdominally)

321

912

1.77

18.01

1.2

93.98

102.50

u/l

0.48

271

781

Sequelae of external causes of morbidity and mortality

160

753

2.14

18.00

1.3

1.2

87.05

91.63

u/l

0.25

137

631

Obesity and other hyperalimentation

327

1817

1.70

17.99

1.2

1.3

79.78

92.37

u/l

2.04

284

1554

Seropositive rheumatoid arthritis, wide

170

821

2.09

17.89

1.2

81.75

88.63

u/l

0.53

154

697

Psoriatic and enteropathic arthropathies

257

3.02

17.89

1.2

76.00

90.63

u/l

0.66

211

Myocardial infarction

263

1007

1.83

17.85

1.3

111.08

90.62

u/l

1.75

225

853

Diagnoses used for exclusion with ILD

152

704

2.17

17.81

1.2

118.97

96.73

u/l

1.02

131

588

Hard cardiovascular diseases

428

1572

1.61

17.81

1.3

1.2

103.40

90.96

u/l

0.96

374

1350

Bronchitis

541

2131

1.53

17.79

1.3

1.2

107.08

89.23

u/l

2.01

482

1820

Other/unspecified seropositive rheumatoid arthritis

168

810

2.09

17.76

1.2

82.42

87.52

u/l

0.36

152

688

Acute pancreatitis

115

474

2.44

17.71

1.2

127.15

84.31

u/l

2.78

104

391

Other disorders of glucose regulation and pancreatic internal secretion

164

3.58

17.61

1.4

1.2

108.92

93.02

u/l

0.54

139

Cardiodefibrillation

193

980

1.97

17.51

1.2

1.3

107.99

98.80

u/l

0.39

169

816

Chronic ulcer of skin, not elsewhere classified

142

3.78

17.43

1.3

1.2

103.91

92.69

u/l

0.29

117

Iron deficiency anaemia secondary to blood loss (chronic)

100

389

2.59

17.42

1.3

1.2

110.92

83.70

u/l

1.22

325

Abnormal findings on diagnostic imaging of lung

265

1413

1.78

17.41

1.2

106.42

93.70

u/l

0.82

224

1200

Any death

346

1448

1.68

17.33

1.4

1.2

130.19

85.71

u/l

6.90

315

1214

Benign neoplasms

446

1528

1.59

17.30

1.3

1.2

88.56

94.91

u/l

0.54

376

1323

Chronic periodontitis, complicated

307

1761

1.71

17.30

1.4

1.2

97.26

94.52

u/l

0.15

262

1508

Hernia

471

2016

1.56

17.26

1.3

1.2

92.31

93.51

u/l

0.08

403

1741

Other anxiety disorders

234

1076

1.86

17.23

1.2

86.43

87.56

u/l

0.05

199

926

Diseases of the musculoskeletal system and connective tissue

219

559

1.97

17.09

1.2

1.3

93.55

102.25

u/l

0.37

182

482

Vitamin B12 deficiency anaemia

217

3.16

17.07

1.3

1.2

96.86

86.92

u/l

0.33

184

Operations 2 for CAVS

162

751

2.09

17.05

1.3

1.2

112.32

96.23

u/l

1.21

141

620

Calcific aortic valvular stenosis, diagnosis (helper)

162

751

2.09

17.05

1.3

1.2

112.32

96.23

u/l

1.21

141

620

Other necrotizing vasculopathies (FG)

109

4.18

17.00

1.4

1.1

84.87

85.34

u/l

0.01

Overexertion and strenuous or repetitive movements

218

3.15

16.95

1.4

1.2

96.19

82.41

u/l

0.48

181

Calcific aortic valvular stenosis, operated

162

753

2.08

16.93

1.3

1.2

112.32

96.04

u/l

1.23

141

622

Calcific aortic valvular stenosis

162

753

2.08

16.93

1.3

1.2

112.32

96.04

u/l

1.23

141

622

Elevated blood glucose level

159

3.56

16.92

1.2

93.92

82.83

u/l

0.40

135

Diseases of the eye and adnexa

346

1024

1.70

16.88

1.3

1.2

91.61

94.06

u/l

0.13

295

882

Open wound of ankle and foot

224

3.11

16.84

1.3

1.2

130.89

93.22

u/l

1.37

186

Arthropathies

406

1266

1.62

16.82

1.3

86.56

99.36

u/l

1.30

356

1081

Amiodarone users

235

3.06

16.78

1.2

1.3

108.62

95.13

u/l

0.59

195

Other reaction to severe stress, and adjustment disorders

189

969

1.96

16.78

1.3

1.2

98.23

85.73

u/l

0.58

168

830

Calcific aortic valvular stenosis, including rheumatic fever

162

755

2.07

16.76

1.3

1.2

112.32

97.08

u/l

1.11

141

623

Other medical care

245

1138

1.81

16.69

1.4

1.2

131.73

88.41

u/l

4.11

222

961

Senile cataract

336

1218

1.68

16.60

1.4

1.2

102.80

90.95

u/l

0.97

297

1035

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

163

799

2.05

16.52

1.2

82.47

87.62

u/l

0.36

149

678

Spondylopathies (FG)

270

2.87

16.40

1.2

103.99

96.12

u/l

0.21

225

Hypotension

107

443

2.43

16.36

1.4

1.2

90.18

97.70

u/l

0.32

373

Other cataract

249

1030

1.80

16.32

1.4

1.2

108.63

89.14

u/l

1.38

216

869

Invasive ventilation

150

3.58

16.12

1.2

192.75

93.16

u/l

0.70

126

Abnormalities of gait and mobility

307

2.73

16.03

1.2

119.22

87.06

u/l

0.81

262

Postprocedural disorders of digestive system, not elsewhere classified

4.96

15.72

1.9

1.2

128.31

79.16

u/l

1.24

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

4.39

15.69

1.1

1.2

235.62

91.25

u/l

2.53

Symptoms and signs involving the skin and subcutaneous tissue

368

2195

1.59

15.64

1.2

1.3

86.97

94.43

u/l

0.79

324

1881

STROKE

271

1050

1.74

15.56

1.3

105.47

83.04

u/l

1.67

229

892

Accidents

360

1102

1.64

15.53

1.3

1.2

96.27

94.14

u/l

0.10

308

955

Complications of internal orthopaedic prosthetic devices, implants and grafts

136

638

2.15

15.51

1.3

1.2

98.76

90.94

u/l

0.33

117

528

Abnormal findings on diagnostic imaging of other body structures

394

2.48

15.51

1.2

115.68

87.83

u/l

1.23

337

Other acute lower respiratory infections

267

1489

1.71

15.34

1.3

1.2

108.63

93.09

u/l

1.11

235

1265

Chronic apical periodontitis

529

1998

1.49

15.31

1.2

1.3

97.27

92.14

u/l

0.40

446

1731

Caries of enamel

468

2024

1.52

15.28

1.3

88.13

91.85

u/l

0.30

404

1740

Factors influencing health status and contact with health services

122

257

2.39

15.22

1.2

93.20

80.50

u/l

0.71

102

217

Diseases of the respiratory system

297

869

1.72

15.18

1.2

93.31

79.90

u/l

1.38

262

735

Volume depletion

186

3.20

15.15

1.3

1.2

138.08

103.43

u/l

0.72

154

Other antidepressants

477

1603

1.52

15.10

1.2

1.3

92.72

96.24

u/l

0.25

403

1381

Valvular operations

277

2.76

15.10

1.4

1.3

165.92

92.63

u/l

2.13

230

Need for other prophylactic measures

115

3.88

15.03

1.1

1.2

76.85

82.87

u/l

0.22

101

Other metabolic disorders

306

2.67

15.03

1.2

76.50

87.70

u/l

0.65

260

All influenza (not pneumonia)

278

2.75

14.99

1.4

1.1

89.51

94.74

u/l

0.18

232

Mycoses, including avohilmo

450

2269

1.51

14.96

1.3

1.2

92.02

92.44

u/l

0.03

391

1953

Other dorsopathies, not elsewhere classified

456

1549

1.53

14.94

1.2

1.3

89.20

95.26

u/l

0.51

386

1338

Sequelae with surgical and medical care as external cause

124

570

2.19

14.92

1.3

1.2

88.68

92.41

u/l

0.16

105

480

Diabetic neuropathy

318

2.63

14.85

1.4

1.3

122.97

105.53

u/l

0.52

274

Hypoglycaemia, other or unspecified

130

3.66

14.80

1.4

1.2

115.68

92.31

u/l

0.75

110

Soft tissue disorders

457

1534

1.53

14.79

1.3

85.97

96.52

u/l

1.27

393

1321

Other external causes of accidental injury

356

1102

1.62

14.73

1.3

1.2

94.93

94.14

u/l

0.04

305

955

Myocardial infarction, strict

235

937

1.78

14.72

1.3

110.48

91.68

u/l

1.31

201

795

Acute pancreatitis (for exclusion)

115

518

2.23

14.55

1.2

127.15

92.64

u/l

1.89

104

427

Osteoporosis with pathological fracture (FG)

181

3.19

14.51

1.2

1.1

117.35

76.91

u/l

1.29

154

Falls/tendency to fall

476

1586

1.51

14.33

1.3

1.2

98.97

92.57

u/l

0.46

407

1374

Persons encountering health services for examination and investigation

266

768

1.74

14.31

1.2

98.09

89.76

u/l

0.47

223

653

Malignant neoplasm of breast, HER-negative

123

549

2.17

14.30

1.3

1.2

64.69

77.48

u/l

1.29

106

474

Depression or dysthymia

321

1071

1.64

14.20

1.3

99.64

95.30

u/l

0.22

277

926

AV-block

321

2.46

14.07

1.3

1.2

113.03

93.75

u/l

0.97

271

Major coronary heart disease event excluding revascularizations

309

1252

1.63

13.97

1.3

1.2

105.06

90.76

u/l

1.29

267

1063

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

4.17

13.95

1.1

1.2

180.78

88.31

u/l

1.25

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

359

2.45

13.94

1.4

1.2

112.46

90.45

u/l

0.56

304

Personality disorders, excluding more controls

123

578

2.13

13.91

1.1

1.2

98.19

82.30

u/l

0.80

101

499

Degeneration of macula and posterior pole

257

1172

1.70

13.87

1.3

1.2

101.50

94.55

u/l

0.43

210

1009

Mycoses

153

783

1.96

13.82

1.4

1.2

111.10

90.01

u/l

1.08

138

652

Tubulo-interstitial nephritis, not specified as acute or chronic

113

3.75

13.78

1.2

107.92

80.04

u/l

1.13

Intestinal malabsorption

100

3.96

13.72

1.4

1.2

140.74

78.93

u/l

1.73

Ischemic heart diseases

414

1621

1.52

13.68

1.3

1.2

100.52

93.12

u/l

0.53

358

1398

Papulosquamous disorders

212

1208

1.76

13.63

1.3

1.2

91.77

91.13

u/l

0.03

187

1013

Abnormal weight loss

215

2.91

13.58

1.3

1.2

100.61

84.58

u/l

0.82

185

Type 2 diabetes, strict (exclude DM1)

435

1686

1.50

13.48

1.2

1.3

91.42

88.80

u/l

0.21

373

1437

Acute upper respiratory infections of multiple and unspecified sites

367

1736

1.55

13.44

1.3

1.2

105.32

89.63

u/l

1.14

330

1467

Psoriasis

159

833

1.92

13.42

1.3

1.2

92.72

91.31

u/l

0.06

138

693

Injuries to unspecified part of trunk, limb or body region

222

2.86

13.39

1.3

1.2

117.88

82.53

u/l

1.29

192

Injuries to the thorax

231

1354

1.71

13.39

1.3

1.2

91.20

96.93

u/l

0.43

201

1146

Fracture of rib(s), sternum and thoracic spine

165

876

1.89

13.38

1.3

1.2

94.21

100.15

u/l

0.31

139

730

Gastric ulcer

422

2.31

13.36

1.2

120.72

97.02

u/l

0.82

349

Other diseases of anus and rectum

155

803

1.93

13.36

1.3

1.2

95.50

89.24

u/l

0.32

135

682

Hypoparathyroidism

4.36

13.16

1.3

1.2

91.89

70.96

u/l

0.51

Conduction disorders

143

575

2.00

13.12

1.2

104.21

87.41

u/l

1.15

130

479

Type 2 diabetes, definitions combined

429

1668

1.50

13.11

1.2

1.3

91.34

88.45

u/l

0.24

367

1423

Benign neoplasm: Colon, unspecified

144

736

1.97

13.10

1.2

1.3

136.02

92.16

u/l

1.78

121

609

Sciatica+with lumbago

254

1354

1.67

13.10

1.3

87.48

94.73

u/l

0.53

217

1163

Acute bronchitis

209

1177

1.75

13.05

1.3

1.2

112.72

93.08

u/l

1.22

187

989

Seropositive rheumatoid arthritis, strict definition

428

2.28

12.97

1.2

74.06

88.56

u/l

1.18

362

Emergency coronary revascularization (for ACS)

422

1704

1.50

12.95

1.3

1.2

105.81

92.65

u/l

1.19

366

1464

Colectomy operation

441

2.26

12.93

1.4

1.2

108.63

94.38

u/l

0.50

369

Malignant neoplasm of breast, ER-negative, including Hilmo

127

581

2.06

12.92

1.3

1.2

65.94

77.90

u/l

1.19

110

502

Percutaneous Coronary Intervention

392

1573

1.52

12.86

1.3

1.2

105.20

91.94

u/l

1.12

341

1354

Malignant neoplasm of digestive organs, including Hilmo

202

836

1.78

12.85

1.2

168.73

87.27

u/l

2.84

175

708

Benign neoplasm: Stomach

250

2.71

12.83

1.3

1.2

98.00

84.98

u/l

0.54

213

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

392

2.32

12.82

1.4

1.2

111.19

90.49

u/l

0.54

333

Asthma, hospital admissions , main diagnosis only

393

2287

1.50

12.82

1.3

1.2

98.90

93.51

u/l

0.33

342

1964

Exposure to other specified factors

384

2197

1.50

12.74

1.3

1.2

89.59

93.03

u/l

0.24

335

1880

Conjunctivitis (acute, non atopic), including avohilmo

476

1978

1.46

12.66

1.2

1.3

91.90

94.46

u/l

0.18

404

1707

Persons with potential health hazards related to communicable diseases

168

905

1.85

12.64

1.3

1.2

112.92

93.09

u/l

0.65

150

777

Other pleural conditions

235

2.75

12.63

1.3

1.2

140.60

102.16

u/l

1.22

197

Postprocedural endocrine and metabolic disorders, not elsewhere classified

287

2.56

12.58

1.2

75.94

89.02

u/l

0.77

245

Unspecified haematuria

205

957

1.75

12.50

1.2

1.3

116.18

100.35

u/l

0.95

174

803

Intestinal adhesions without obstruction

177

3.02

12.43

1.3

129.63

90.98

u/l

1.21

150

Acute upper respiratory infections

495

2065

1.44

12.40

1.3

1.2

96.85

91.26

u/l

0.47

443

1759

Genitourinary diseases

217

617

1.77

12.38

1.3

101.41

90.74

u/l

0.61

185

520

Other special examinations and investigations of persons without complaint or reported diagnosis

255

768

1.69

12.36

1.2

101.34

89.76

u/l

0.71

219

653

ILD, hospital admissions

381

2.33

12.31

1.1

1.2

112.30

93.21

u/l

0.49

317

Any mental disorder

500

1737

1.44

12.31

1.2

1.3

100.11

93.94

u/l

0.40

422

1503

Fracture of lower leg, including ankle

281

1738

1.59

12.30

1.2

89.33

91.95

u/l

0.16

256

1482

Lymphoid leukaemia

118

3.52

12.24

1.2

123.06

89.81

u/l

0.77

102

Disorders of sclera, cornea, iris and ciliary body

270

1689

1.60

12.23

1.3

97.97

91.59

u/l

0.46

247

1423

Coronary revascularization (ANGIO or CABG)

389

1574

1.50

12.23

1.3

1.2

104.14

91.90

u/l

1.00

338

1355

Chronic lower respiratory diseases

550

2051

1.41

12.23

1.3

1.2

105.19

92.00

u/l

1.18

468

1772

Dorsopathies

451

1556

1.47

12.21

1.3

86.41

96.05

u/l

0.98

389

1343

Disorders of synovium and tendon

255

1326

1.64

12.21

1.3

83.42

92.92

u/l

0.72

226

1138

Seronegative rheumatoid arthritis

268

2.60

12.20

1.2

1.1

78.90

86.44

u/l

0.32

223

Ischaemic heart disease, wide definition

384

1573

1.51

12.16

1.3

1.2

96.06

90.94

u/l

0.42

326

1348

Congenital malformations, deformations and chromosomal abnormalities

267

1578

1.61

12.14

1.3

86.30

89.34

u/l

0.19

230

1349

Alcohol use disorder, Swedish definition

248

1378

1.64

12.14

1.2

1.3

119.97

98.24

u/l

1.48

203

1188

Obesity related asthma

181

1022

1.78

12.08

1.3

1.2

90.13

89.22

u/l

0.04

150

865

Persistent mood disorders

107

506

2.13

12.07

1.2

83.88

87.06

u/l

0.12

422

Zoster [herpes zoster], including avohilmo

275

1671

1.59

12.06

1.3

1.2

101.17

91.63

u/l

0.54

224

1429

KRA_PSY_EATING, excluding more controls

3.87

12.05

1.3

79.63

73.25

u/l

0.16

Other interstitial pulmonary diseases

386

2.30

11.96

1.1

1.2

112.30

95.78

u/l

0.40

317

Retention of urine

157

681

1.87

11.92

1.2

111.78

100.05

u/l

0.62

136

569

COPD (mode)

145

590

1.92

11.89

1.2

117.27

79.52

u/l

2.67

120

496

Cyst of kidney

156

3.11

11.82

1.4

1.2

68.09

94.99

u/l

2.05

135

Interstitial lung disease

388

2.28

11.82

1.1

1.2

112.30

96.12

u/l

0.39

320

Interstitial lung disease endpoints

388

2.28

11.82

1.1

1.2

112.30

96.12

u/l

0.39

320

Other arrhythmias

286

1351

1.58

11.79

1.3

1.2

102.11

86.03

u/l

1.27

244

1159

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

293

1712

1.56

11.75

1.3

85.64

90.05

u/l

0.32

252

1460

Chronic rhinitis, nasopharyngitis and pharyngitis

174

982

1.78

11.64

1.3

1.2

83.27

91.85

u/l

0.54

144

826

Injuries to the head

516

2174

1.41

11.59

1.2

1.3

97.50

94.59

u/l

0.20

426

1891

Weight loss

246

2.62

11.59

1.3

1.2

100.38

85.33

u/l

0.78

210

Other (not insulin) diabetes medications

444

1800

1.45

11.59

1.2

96.76

88.05

u/l

0.91

387

1535

Early onset COPD, excluding more controls

442

2.18

11.57

1.2

112.08

84.26

u/l

1.15

367

Coronary atherosclerosis

321

1313

1.55

11.55

1.3

98.43

90.33

u/l

0.62

273

1120

Recurrent or chronic depression

192

762

1.75

11.49

1.2

1.3

96.00

91.19

u/l

0.16

164

658

Other (seronegative) rheumatoid arthritis, wide

114

564

2.03

11.45

1.2

88.85

90.13

u/l

0.05

102

472

258

1444

1.60

11.42

1.2

1.3

117.11

97.82

u/l

1.32

214

1247

Other and unspecified local infections of skin and subcutaneous tissue

214

2.73

11.38

1.4

1.1

123.96

89.08

u/l

0.68

180

Conjunctivitis

364

1976

1.49

11.36

1.3

1.2

82.19

89.10

u/l

0.54

318

1694

Trigger finger

414

2.21

11.36

1.3

1.2

84.13

90.99

u/l

0.32

349

Injuries to the ankle and foot

333

1887

1.51

11.35

1.4

1.2

91.41

90.74

u/l

0.04

293

1612

Injury of unspecified body region

160

3.03

11.33

1.3

1.2

110.41

80.25

u/l

1.16

139

Nonorganic sleeping disorders, excluding more controls

101

480

2.11

11.27

1.2

74.65

85.57

u/l

0.64

411

Duodenal ulcer

227

2.66

11.21

1.3

1.2

98.31

95.61

u/l

0.07

186

Disorders of conjunctiva

396

2107

1.46

11.21

1.3

1.2

82.39

91.31

u/l

0.83

346

1800

Major coronary heart disease event

407

1667

1.46

11.19

1.3

1.2

104.26

92.38

u/l

1.01

353

1430

Symptoms and signs involving the urinary system

366

1867

1.48

11.16

1.3

1.2

98.59

96.25

u/l

0.13

311

1600

Scar conditions and fibrosis of skin

4.11

11.15

1.2

72.36

75.13

u/l

0.09

ILD, hospital admissions 1, main diag only

337

2.33

11.02

1.1

1.2

116.04

94.94

u/l

0.49

282

Fracture of shoulder and upper arm

194

1146

1.70

11.02

1.3

1.2

98.40

89.43

u/l

0.51

166

973

Candidiasis, including avohilmo

157

875

1.80

11.00

1.3

1.2

108.31

87.73

u/l

1.09

136

741

Spondylosis

265

1313

1.58

10.97

1.2

1.3

87.11

98.48

u/l

1.03

222

1126

Other local infections of skin and subcutaneous tissue

236

2.61

10.92

1.4

1.2

123.63

88.01

u/l

0.72

198

Injuries to the knee and lower leg

546

2133

1.39

10.92

1.3

1.2

97.28

92.82

u/l

0.33

472

1832

267

1483

1.57

10.90

1.2

1.3

115.95

97.54

u/l

1.28

220

1279

Other embolism and thrombosis

315

2.37

10.82

1.3

1.2

92.21

90.27

u/l

0.06

263

Dilated cardiomyopathy

261

2.51

10.79

1.2

130.70

97.34

u/l

1.53

216

Acute sinusitis

240

1366

1.60

10.74

1.4

1.2

86.05

87.46

u/l

0.09

219

1150

Asthma, including avohilmo

536

2135

1.38

10.71

1.3

1.2

101.32

94.53

u/l

0.51

458

1844

Unspecified fall

252

1573

1.58

10.68

1.3

1.2

92.06

94.43

u/l

0.10

219

1340

Malignant neoplasm of digestive organs

177

778

1.75

10.67

1.2

169.83

86.40

u/l

2.59

155

659

Other joint disorders

361

1265

1.49

10.62

1.2

1.3

78.74

99.33

u/l

3.15

316

1080

Lichen simplex chronicus and prurigo

135

3.14

10.57

1.3

1.2

90.71

81.90

u/l

0.33

113

Arterial embolism and thrombosis

115

3.34

10.53

1.3

1.2

105.50

98.00

u/l

0.12

Other specified/unspecified bacterial intestinal infections

141

3.08

10.47

1.3

1.2

112.78

84.76

u/l

0.73

118

Non-selective monoamine reuptake inhibitors

192

1102

1.68

10.42

1.2

1.3

94.47

93.93

u/l

0.02

167

933

Lung cancer and mesothelioma

354

2.17

10.41

1.3

1.2

116.95

88.69

u/l

1.06

294

Type 2 diabetes, definitions combined, including avohilmo

416

1681

1.43

10.24

1.2

1.3

90.99

88.43

u/l

0.20

353

1433

Reactive arthropathies

170

2.85

10.20

1.4

1.1

80.12

91.44

u/l

0.42

140

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

178

1052

1.70

10.20

1.2

80.54

89.35

u/l

0.60

156

890

Venous thromboembolism

266

1667

1.54

10.18

1.3

1.2

95.47

95.04

u/l

0.03

238

1411

Urticaria and erythema

180

1067

1.69

10.18

1.2

98.14

87.59

u/l

0.39

163

901

Dizziness and giddiness

355

1895

1.46

10.15

1.2

1.3

93.78

94.32

u/l

0.03

300

1640

Other renal tubulo-interstitial diseases

5.35

10.14

1.2

64.90

82.55

u/l

0.63

Malignant neoplasm of skin, including Hilmo

234

978

1.61

10.12

1.4

1.2

96.23

86.46

u/l

0.69

193

830

Obesity due to excess calories

219

1368

1.61

10.09

1.2

1.3

79.09

90.15

u/l

1.21

186

1170

Dipeptidyl peptidase 4 (DPP-4) inhibitors

279

1436

1.53

9.97

1.2

1.3

108.66

92.41

u/l

1.61

242

1223

Other specified and unspecified personality disorders

163

2.84

9.78

1.2

1.1

113.87

84.76

u/l

0.57

140

Benign neoplasm: Sigmoid colon

105

535

1.97

9.78

1.3

1.2

90.87

93.92

u/l

0.11

448

Diseases of pulp and periapical tissues, including avohilmo

461

1708

1.40

9.70

1.2

1.3

95.05

95.29

u/l

0.01

381

1476

Misadventures to patients during surgical and medical care

370

2.18

9.66

1.3

1.2

118.28

88.85

u/l

1.06

315

Convulsions, not elsewhere classified

463

2.03

9.63

1.2

111.65

89.19

u/l

0.80

379

Substance abuse, excluding more controls

236

1262

1.57

9.56

1.2

1.3

115.13

92.70

u/l

1.64

195

1086

Personality disorders

123

666

1.85

9.54

1.1

1.2

98.19

84.15

u/l

0.67

101

572

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

114

583

1.90

9.53

1.7

1.2

105.17

87.36

u/l

0.81

106

493

Intracranial trauma

251

1093

1.55

9.49

1.3

106.90

97.54

u/l

0.47

210

951

Viral hepatitis, including avohilmo

139

2.97

9.45

1.3

1.2

90.00

100.13

u/l

0.19

118

Other disorders of lacrimal gland

197

1221

1.62

9.43

1.3

1.2

84.07

87.26

u/l

0.13

165

1033

Candidiasis

361

2.17

9.41

1.4

1.2

137.82

87.08

u/l

1.75

307

malignant neoplasm of male genital organs

107

323

2.00

9.40

1.7

1.2

107.72

106.01

u/l

0.04

267

Malignant neoplasm of prostate

104

305

2.02

9.39

1.7

1.2

105.56

104.23

u/l

0.03

252

Pacemaker

172

956

1.68

9.35

1.3

1.2

119.11

97.76

u/l

1.83

156

789

Disorders of continuity of bone

231

2.49

9.34

1.3

1.2

74.65

86.60

u/l

0.59

200

Disorders of skin appendages

225

1439

1.56

9.20

1.3

80.70

90.03

u/l

0.84

192

1225

Reactive arthropathies, FINNGEN

115

3.15

9.18

1.4

1.1

84.81

87.44

u/l

0.06

Other diseases of pericardium

3.72

9.17

1.5

1.2

144.79

97.03

u/l

0.82

Dysphagia

124

683

1.82

9.13

1.4

1.3

123.15

85.30

u/l

1.21

105

573

Retinal detachments and breaks

174

1055

1.66

9.11

1.2

92.85

92.09

u/l

0.03

146

898

Nerve, nerve root and plexus disorders

479

2108

1.37

9.09

1.3

1.2

85.33

96.48

u/l

1.75

417

1811

External causes of morbidity and mortality

266

868

1.54

9.08

1.2

97.05

95.43

u/l

0.06

225

751

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

387

2.10

9.01

1.2

102.01

88.90

u/l

0.54

329

Disorders of adult personality and behaviour

127

709

1.80

8.95

1.2

96.68

85.32

u/l

0.53

105

607

Panic disorder

298

2.26

8.92

1.2

89.39

84.91

u/l

0.15

252

Soft tissue disorders related to use, overuse and pressure

141

814

1.74

8.87

1.3

1.2

73.65

94.22

u/l

2.70

121

687

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

4.53

8.86

1.4

1.1

125.86

96.83

u/l

0.34

Multiple myeloma

4.53

8.86

1.4

1.1

125.86

96.83

u/l

0.34

Neurological diseases, wide definition

213

2.13

8.85

1.2

1.3

79.26

123.59

u/l

1.22

185

Cerebrovascular diseases

345

1677

1.43

8.75

1.3

1.2

111.10

92.34

u/l

1.46

287

1440

Phobic anxiety disorders

244

2.38

8.72

1.1

1.2

98.81

90.89

u/l

0.21

209

Chronic sinusitis

205

1307

1.57

8.69

1.4

1.2

92.79

92.14

u/l

0.02

182

1105

Disorders of the thyroid gland

416

1952

1.38

8.69

1.2

1.3

85.98

97.12

u/l

1.47

361

1675

Hypertrophic cardiomyopathy

3.42

8.64

1.4

1.2

112.36

82.79

u/l

0.70

Eating disorder

114

3.08

8.62

1.3

1.2

79.63

83.49

u/l

0.09

105

Other intervertebral disc disorders

349

1459

1.43

8.60

1.2

1.3

85.61

97.19

u/l

1.18

289

1257

Other disorders of veins

211

1340

1.55

8.52

1.3

1.2

84.74

88.27

u/l

0.26

178

1137

Other viral diseases, including avohilmo

162

972

1.65

8.51

1.2

93.50

88.61

u/l

0.19

143

834

Hypothyreosis and Thyroxine purchase for inclusion criteria

410

1948

1.38

8.46

1.2

1.3

84.54

95.67

u/l

1.54

359

1663

Generalized anxiety disorder

337

2.14

8.45

1.2

71.75

85.12

u/l

0.79

289

Other viral diseases

126

712

1.77

8.44

1.2

101.12

97.70

u/l

0.09

114

604

Viral hepatitis

132

2.90

8.43

1.3

1.2

90.79

100.38

u/l

0.16

112

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

103

447

1.90

8.42

1.2

115.72

88.65

u/l

1.20

374

Thyrotoxicosis, other and/or unspecified

104

557

1.88

8.42

1.2

79.77

90.23

u/l

0.48

470

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

258

1667

1.49

8.41

1.2

81.81

88.78

u/l

0.40

226

1433

Macular pucker

439

1.99

8.41

1.4

1.2

113.99

87.78

u/l

1.13

366

Zoster [herpes zoster]

101

537

1.89

8.36

1.2

94.16

93.90

u/l

0.01

449

Viral infections characterized by skin and mucous membrane lesions

198

1265

1.57

8.36

1.2

92.49

92.21

u/l

0.01

177

1070

Ischaemic Stroke, excluding all haemorrhages

265

1315

1.49

8.34

1.2

107.61

94.28

u/l

0.86

227

1118

Protozoal diseases

3.87

8.27

1.2

86.56

85.04

u/l

0.03

Nonorganic sleeping disorders

101

539

1.88

8.27

1.2

74.65

89.43

u/l

0.97

466

Malignant melanoma, including Hilmo

394

2.04

8.26

1.3

1.2

102.31

84.33

u/l

0.93

330

Multiple myeloma, including Hilmo

3.45

8.23

1.4

1.1

139.36

90.07

u/l

0.91

Stroke, excluding SAH

279

1376

1.47

8.19

1.3

1.2

111.08

92.45

u/l

1.18

240

1176

Fissure and fistula of anal and rectal regions

106

577

1.84

8.16

1.1

1.2

81.83

88.50

u/l

0.35

483

Other symptoms and signs involving cognitive functions and awareness

228

1336

1.52

8.14

1.2

1.3

94.08

97.42

u/l

0.17

193

1147

Asthma/COPD (KELA code 203)

418

2047

1.37

8.14

1.3

1.2

103.60

91.26

u/l

1.02

359

1769

Functional dyspepsia

126

723

1.75

8.14

1.2

99.19

86.20

u/l

0.57

107

617

Other/unspecified rheumatoid arthritis

317

2.16

8.13

1.2

85.69

80.77

u/l

0.23

266

Nonischemic cardiomyopathy

210

2.44

8.11

1.2

1.3

101.12

91.15

u/l

0.27

174

Protozoal diseases, including avohilmo

3.81

8.09

1.2

86.56

84.05

u/l

0.05

Vocal cord dysfunction

167

2.54

8.09

1.3

70.60

75.46

u/l

0.16

138

Erosion of teeth , including avohilmo

121

688

1.77

8.07

1.2

116.09

87.81

u/l

0.81

584

Cerebral palsy and other paralytic syndromes

254

2.30

8.06

1.6

1.2

91.88

92.24

u/l

0.01

213

Other disorders of skin and subcutaneous tissue, not elsewhere classified

345

2.10

8.02

1.3

1.2

94.79

91.30

u/l

0.10

288

Non-allergic asthma (mode), excluding more controls

408

2.00

8.02

1.3

1.2

115.10

72.86

u/l

1.60

346

Allergic conjunctivitis

266

1755

1.46

8.01

1.3

1.2

81.88

88.33

u/l

0.38

230

1516

Other secondary coxarthrosis

3.56

7.99

1.2

149.00

79.09

u/l

0.63

Pulmonary heart disease, diseases of pulmonary circulation

157

961

1.64

7.98

1.3

1.2

102.42

94.14

u/l

0.47

139

794

Disorders of eyelid, lacrimal system and orbit

399

2140

1.37

7.97

1.3

1.2

96.37

95.47

u/l

0.04

339

1848

Malignant neoplasm of skin

213

937

1.54

7.88

1.3

1.2

93.86

84.98

u/l

0.62

177

794

Postmenopausal osteoporosis with pathological fracture

166

2.62

7.86

1.2

122.97

79.34

u/l

1.01

139

Malignant melanoma

348

2.08

7.85

1.3

1.2

102.94

82.58

u/l

1.02

289

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

451

1.94

7.79

1.2

102.17

88.29

u/l

0.63

382

Other arthrosis

234

1043

1.51

7.77

1.2

1.3

89.01

101.69

u/l

1.04

208

888

Non-small cell lung cancer, including Hilmo

302

2.12

7.73

1.1

1.2

116.64

88.05

u/l

0.98

253

Other viral hepatitis

106

3.04

7.73

1.4

1.2

66.67

101.75

u/l

1.10

Transport accidents

187

995

1.57

7.72

1.3

1.2

97.63

89.46

u/l

0.36

156

860

Malignant neoplasm of prostate, including Hilmo

101

315

1.90

7.70

1.7

1.2

106.85

104.26

u/l

0.06

261

Disorders of vitreous body and globe

259

1685

1.46

7.69

1.3

1.2

83.91

90.95

u/l

0.73

223

1439

Superficial injury of head

117

668

1.76

7.68

1.2

96.95

88.65

u/l

0.38

566

Pruritus

292

2.17

7.66

1.2

117.80

82.79

u/l

0.72

252

Other viral hepatitis, including avohilmo

112

2.97

7.65

1.4

1.2

65.43

103.38

u/l

1.30

Neuromuscular dysfunction of bladder

174

2.55

7.65

1.4

1.1

88.71

86.84

u/l

0.06

147

Procreative management

159

807

1.63

7.65

1.3

1.2

97.63

97.92

u/l

0.01

141

699

Thiazolidinediones

273

2.21

7.64

1.1

1.2

127.29

86.84

u/l

1.09

230

Allergic asthma (mode), excluding more controls

457

1.91

7.60

1.3

1.2

86.79

74.09

u/l

0.62

380

Selective serotonin reuptake inhibitors

420

1609

1.36

7.59

1.3

95.58

96.17

u/l

0.03

362

1387

Rash and other nonspecific skin eruption

236

2.30

7.57

1.3

1.2

70.39

84.77

u/l

1.09

201

Disorders of vitreous body

254

1663

1.46

7.54

1.3

1.2

84.21

90.79

u/l

0.65

219

1422

Trochanteric bursitis

436

1.94

7.53

1.3

1.2

81.10

87.18

u/l

0.34

379

Diabetic maculopathy

314

2.09

7.53

1.3

1.2

117.42

100.36

u/l

0.68

266

Obsessive-compulsive disorder

3.17

7.52

1.3

1.2

129.50

86.22

u/l

0.32

Urticaria

140

846

1.66

7.51

1.2

91.08

88.96

u/l

0.06

127

723

Keratitis

165

1039

1.59

7.50

1.3

1.2

95.17

90.03

u/l

0.25

149

872

Malignant neoplasm of respiratory system and intrathoracic organs

399

1.90

7.46

1.1

1.2

119.44

91.54

u/l

1.04

332

Hypothyroidism, other/unspecified

384

1852

1.36

7.46

1.2

1.3

85.18

96.50

u/l

1.46

336

1583

Non-small cell lung cancer

192

2.43

7.44

1.2

123.88

88.84

u/l

0.91

158

Exclusions for E4_PCOS_CONSORTIUM

330

1473

1.40

7.43

1.3

1.2

82.88

89.76

u/l

0.71

286

1266

Squamous cell neoplasms and carcinomas of the skin

183

2.47

7.38

1.2

103.13

88.46

u/l

0.52

149

Other disorders of bone

460

1.90

7.38

1.3

1.2

82.69

86.09

u/l

0.15

390

Exclusions for E4_PCOS_BROAD

425

1.94

7.36

1.3

1.2

86.20

99.78

u/l

0.66

359

Sleep disorders (combined)

484

1913

1.32

7.35

1.2

1.3

84.27

96.36

u/l

1.76

402

1659

Hydronephrosis

214

2.35

7.35

1.3

1.2

93.76

81.80

u/l

0.41

178

Concussion

210

1079

1.51

7.31

1.2

1.3

105.88

96.74

u/l

0.41

177

938

Memory loss

221

2.33

7.31

1.2

102.30

96.35

u/l

0.13

184

Polyuria

102

570

1.80

7.27

1.4

1.3

113.73

92.56

u/l

0.70

475

Discitis, unspecified

5.89

7.26

1.4

1.2

115.42

81.54

u/l

0.54

Thyrotoxicosis

129

771

1.68

7.25

1.2

77.56

87.22

u/l

0.57

108

658

Spinal stenosis

235

1175

1.48

7.25

1.2

83.94

96.05

u/l

1.11

197

1009

Stomatitis and related lesions

542

1.82

7.23

1.3

1.2

137.55

90.47

u/l

0.54

466

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

232

2.27

7.21

1.3

1.2

96.11

86.03

u/l

0.38

192

Other and unspecified injuries of head

156

2.58

7.18

1.1

1.2

84.00

78.15

u/l

0.21

133

Biomechanical lesions, not elsewhere classified

117

2.85

7.12

1.3

1.2

71.64

79.45

u/l

0.24

101

Unspecified acute lower respiratory infection

348

2.02

7.11

1.3

1.2

105.88

88.23

u/l

0.79

285

Benign neoplasm: Adrenal gland

193

2.40

7.10

1.3

1.2

86.10

82.49

u/l

0.10

164

Unstable angina pectoris

161

796

1.59

7.09

1.2

1.3

113.44

93.58

u/l

1.07

138

664

Non-allergic asthma (mode)

427

1.91

7.08

1.3

1.2

115.10

76.46

u/l

1.41

357

Coronary artery bypass grafting

103

425

1.80

7.07

1.3

126.48

97.13

u/l

1.08

363

Calculus of kidney and ureter

131

793

1.66

7.02

1.3

87.48

99.39

u/l

0.79

111

659

Benign neoplasm of other and unspecified endocrine glands

350

2.01

7.02

1.4

1.2

84.57

89.97

u/l

0.22

299

malignant neoplasm of male genital organs, including Hilmo

101

332

1.83

6.99

1.7

1.2

108.46

104.78

u/l

0.08

273

Retinal vascular occlusion

277

2.14

6.98

1.2

103.25

95.66

u/l

0.21

237

Fracture of forearm

268

1697

1.42

6.98

1.2

76.10

88.57

u/l

1.83

227

1461

Retinal vascular disorders

284

2.12

6.96

1.2

102.92

96.72

u/l

0.17

243

Congenital malformations and deformations of the musculoskeletal system

164

2.50

6.91

1.3

1.2

93.69

82.11

u/l

0.12

141

Biguanides

425

1933

1.33

6.88

1.2

1.3

100.31

91.56

u/l

0.82

369

1653

Abnormalities of heart beat

158

975

1.58

6.87

1.2

1.3

97.99

84.29

u/l

0.84

135

828

Polymyalgia rheumatica

353

1.99

6.86

1.1

1.2

84.42

90.11

u/l

0.18

299

Other and unspecified psoriasis

154

2.55

6.85

1.2

107.71

83.95

u/l

0.49

128

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

228

2.25

6.82

1.3

1.2

83.39

94.49

u/l

0.55

194

Asthma and allergy, excluding more controls

219

2.26

6.77

1.3

1.1

77.80

73.31

u/l

0.11

183

Deforming dorsopathies

131

804

1.63

6.67

1.3

75.94

90.04

u/l

1.34

118

680

Specific personality disorders

549

1.77

6.66

1.2

102.22

85.92

u/l

0.60

469

Other disorders of eye and adnexa

364

1.96

6.65

1.4

1.2

76.14

91.33

u/l

0.73

315

Asthma and allergy

221

2.24

6.63

1.3

1.2

77.80

76.13

u/l

0.04

185

Allergic asthma (mode)

479

1.82

6.63

1.3

1.2

86.79

78.75

u/l

0.34

399

Hernia of abdominal wall

198

1338

1.48

6.59

1.3

103.89

94.10

u/l

0.56

177

1127

Myalgia

111

655

1.70

6.58

1.3

1.2

75.46

90.08

u/l

1.40

553

Other specified and unspecified disorders of eye and adnexa

3.28

6.57

1.6

1.2

72.78

77.20

u/l

0.09

Urolithiasis

139

870

1.60

6.55

1.3

85.02

98.75

u/l

1.04

117

731

Undetermined asthma, excluding more controls

284

2.08

6.55

1.4

1.1

116.93

75.36

u/l

0.93

236

Visual disturbances and blindness

239

1675

1.43

6.53

1.3

1.2

98.33

95.50

u/l

0.11

203

1427

Inflammatory diseases of the central nervous system

176

2.40

6.52

1.2

93.65

86.79

u/l

0.16

146

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

199

899

1.50

6.51

1.4

1.2

98.64

85.44

u/l

0.82

163

761

Shoulder lesions

314

1366

1.38

6.49

1.2

1.3

90.64

98.32

u/l

0.60

267

1170

Thyroiditis, ILD-related definition

246

2.17

6.48

1.3

1.2

75.11

78.97

u/l

0.13

208

Mental and behavioural disorders due to psychoactive substance use

244

1573

1.42

6.46

1.2

1.3

112.13

95.64

u/l

1.08

203

1353

In situ neoplasms

191

1288

1.49

6.44

1.2

99.59

91.14

u/l

0.52

169

1093

Diffuse large B-cell lymphoma, including Hilmo

2.94

6.43

1.3

1.1

306.36

86.38

u/l

0.91

Diffuse large B-cell lymphoma, helper endpoint

2.94

6.43

1.3

1.1

306.36

86.38

u/l

0.91

Diffuse large B-cell lymphoma

2.94

6.43

1.3

1.1

306.36

86.38

u/l

0.91

Injuries to the elbow and forearm

322

2035

1.36

6.40

1.2

1.3

76.92

92.23

u/l

2.87

273

1749

Eating disorders

159

2.46

6.39

1.2

86.26

82.29

u/l

0.10

142

General examination and investigation of persons without complaint and reported diagnosis

218

767

1.48

6.39

1.3

1.2

104.89

89.79

u/l

0.66

185

652

Special screening examination for infectious and parasitic diseases

310

1.89

6.36

1.2

87.23

78.10

u/l

0.35

260

Mental disorders, not otherwise specified

148

2.51

6.34

1.2

69.13

78.47

u/l

0.53

122

Substance abuse

236

1541

1.42

6.32

1.2

1.3

115.13

95.50

u/l

1.34

195

1329

Fall involving bed

3.28

6.29

1.1

1.3

118.06

82.92

u/l

0.71

Bronchiectasis

198

2.29

6.28

1.4

1.2

80.77

87.28

u/l

0.20

167

Carbimazole or st.post thyroidectomy, condition for graves disease

103

604

1.71

6.28

1.1

1.2

77.43

84.39

u/l

0.28

519

Benign neoplasm: Skin of trunk

2.97

6.28

1.4

1.2

91.18

78.52

u/l

0.31

Neurological diseases

347

1286

1.36

6.27

1.2

1.3

89.74

101.72

u/l

0.95

296

1115

Stroke, including SAH

285

1478

1.39

6.27

1.3

1.2

111.48

93.61

u/l

1.12

243

1267

Isolated proteinuria with specified morphological lesion

7.20

6.27

1.1

1.3

54.79

93.79

u/l

1.06

Benign neoplasm: Rectum

488

1.79

6.20

1.2

103.61

93.80

u/l

0.32

408

Open wound of head

234

1551

1.42

6.15

1.2

1.3

94.85

97.96

u/l

0.16

195

1343

Benign neoplasm: Transverse colon

285

2.05

6.15

1.3

1.2

105.54

90.26

u/l

0.44

237

Malignant neoplasm of bronchus and lung, including Hilmo

411

1.79

6.11

1.3

1.2

110.96

90.60

u/l

0.81

341

Basal cell carcinoma, including Hilmo

192

877

1.49

6.09

1.3

1.2

102.18

85.00

u/l

1.15

159

742

Angina pectoris

250

1177

1.41

6.06

1.2

1.3

106.83

89.79

u/l

1.36

220

1005

Disorders of lacrimal system

216

1486

1.43

6.03

1.3

1.2

83.75

87.37

u/l

0.16

181

1264

Visual disturbances

220

1545

1.43

6.03

1.3

99.20

91.04

u/l

0.38

186

1314

Emotionally unstable personality disorder

221

2.18

6.01

1.1

1.2

90.15

84.72

u/l

0.20

192

Degenerative macular diseases

295

2.01

5.98

1.3

1.2

82.66

87.22

u/l

0.19

251

Retinal detachment with retinal break

310

1.98

5.91

1.2

96.04

88.92

u/l

0.20

259

Corneal scars and opacities

3.56

5.90

1.3

1.2

97.11

79.51

u/l

0.49

Pulmonary embolism

136

870

1.57

5.89

1.3

1.2

95.72

94.18

u/l

0.07

123

719

Mental and behavioural disorders due to alcohol, excluding acute intoxication

176

1179

1.48

5.89

1.2

1.3

117.15

99.35

u/l

0.86

143

1005

Vitamin deficiency

2.84

5.84

1.5

1.2

102.89

76.40

u/l

0.66

Vitamin deficiency, wide

2.84

5.84

1.5

1.2

102.89

76.40

u/l

0.66

Later onset COPD, excluding more controls

363

1.79

5.82

1.1

1.3

104.06

81.13

u/l

1.12

306

Dental caries, including avohilmo

304

1141

1.37

5.80

1.2

103.27

96.07

u/l

0.33

256

981

Psychiatric diseases

407

1560

1.31

5.79

1.2

1.3

93.88

94.52

u/l

0.03

343

1342

Thyrotoxicosis with toxic multinodular goitre

143

2.47

5.78

1.2

94.17

73.51

u/l

0.42

123

Mental and behavioural disorders due to alcohol

202

1339

1.44

5.78

1.2

1.3

114.50

97.86

u/l

0.87

166

1153

Other arterial embolism and thrombosis

3.50

5.74

1.3

1.2

96.14

99.22

u/l

0.03

COPD, hospital admissions 3, with asthma pneumonia sepsis

119

633

1.62

5.73

1.2

111.58

103.33

u/l

0.31

521

Benign neoplasm: Rectum, anus and anal canal

560

1.70

5.73

1.2

106.92

92.58

u/l

0.48

464

Psoriasis vulgaris

501

1.74

5.70

1.2

101.38

93.93

u/l

0.23

418

DVT of lower extremities and pulmonary embolism

189

1300

1.45

5.68

1.3

1.2

91.85

95.67

u/l

0.25

175

1095

Pulmonary heart disease

136

878

1.55

5.68

1.3

1.2

95.72

94.26

u/l

0.06

123

725

Melanocytic naevi

140

910

1.54

5.67

1.3

1.2

90.82

88.23

u/l

0.11

119

766

Undetermined asthma

301

1.97

5.65

1.4

1.1

116.93

82.34

u/l

0.71

251

Fracture of skull and facial bones

540

1.71

5.63

1.3

1.2

114.56

93.22

u/l

0.77

458

Voice disturbances

130

833

1.57

5.62

1.3

1.2

85.11

86.82

u/l

0.08

114

706

Malignant neoplasm of bronchus and lung

350

1.82

5.61

1.1

1.2

114.61

91.48

u/l

0.79

293

Other malignant neoplasms of skin (=non-melanoma skin cancer)

187

868

1.46

5.59

1.3

1.2

95.06

85.14

u/l

0.57

154

733

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

202

2.19

5.59

1.2

148.35

78.32

u/l

1.25

170

Abscess of anal and rectal regions

152

2.38

5.54

1.2

74.64

88.48

u/l

0.32

126

Ventral hernia

112

696

1.61

5.52

1.3

1.2

98.19

90.13

u/l

0.31

580

Malignant neoplasm of pancreas, including Hilmo

165

2.32

5.50

1.2

219.45

84.16

u/l

2.27

138

Injury, poisoning and certain other consequences of external causes

208

723

1.44

5.46

1.2

98.02

96.28

u/l

0.06

177

631

Lumbar disc prolapse

262

1419

1.37

5.46

1.2

1.3

89.07

96.29

u/l

0.47

215

1220

Monoamine oxidase A inhibitors

313

1.93

5.42

1.2

1.3

85.42

91.07

u/l

0.22

266

Other diseases of hard tissues of teeth

224

818

1.42

5.42

1.2

103.49

96.75

u/l

0.29

184

702

Fall on same level involving ice and snow

257

1892

1.36

5.35

1.2

1.3

89.04

91.65

u/l

0.15

220

1613

Viral warts, including avohilmo

564

1.67

5.33

1.2

65.88

90.78

u/l

3.20

482

N06DA Anticholinesterases

899

0.56

5.33

1.1

1.2

78.08

98.58

u/l

1.69

758

Use of anticholinesterases

899

0.56

5.33

1.1

1.2

78.08

98.58

u/l

1.69

758

Other peripheral vascular diseases

174

2.25

5.32

1.2

114.97

79.99

u/l

0.41

152

Cystic fibrosis with pulmonary manifestations

+∞

5.29

2.6

0.0

177.20

—

u/l

—

Delivery

792

0.60

5.28

1.3

76.65

90.74

u/l

0.77

689

Covid-19 suspected case

528

1.69

5.27

1.3

1.2

114.88

83.37

u/l

1.56

454

Spondylopathies in diseases classified elsewhere

6.04

5.25

1.5

1.3

116.62

84.24

u/l

0.30

Atopic dermatitis

240

1390

1.38

5.24

1.3

90.21

88.26

u/l

0.08

207

1197

Delirium, not induced by alcohol and other psychoactive substances

316

1.90

5.24

1.2

96.52

93.90

u/l

0.07

263

Infection due to other mycobacteria

6.01

5.24

1.8

1.2

138.00

74.29

u/l

1.06

Recurrent aphthous stomatitis , including avohilmo

374

1.83

5.23

1.3

1.2

153.15

88.67

u/l

0.52

317

Basal cell carcinoma

180

845

1.46

5.23

1.3

1.2

98.21

85.43

u/l

0.77

151

715

Other complications of surgical and medical care, not elsewhere classified

221

2.09

5.23

1.2

126.62

90.26

u/l

0.56

184

Coxarthrosis [arthrosis of hip](FG)

229

1134

1.39

5.22

1.3

91.86

96.83

u/l

0.24

202

970

Other/unspecified reactive arthropathies

132

2.44

5.21

1.4

1.2

77.37

77.99

u/l

0.02

112

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

189

2.18

5.18

1.3

1.2

103.60

86.47

u/l

0.43

154

Caries of dentine, including avohilmo

327

1263

1.33

5.17

1.2

98.16

97.13

u/l

0.04

278

1086

Malignant neoplasm of urinary organs, including Hilmo

222

2.08

5.17

1.3

1.2

97.10

87.80

u/l

0.23

183

Other keratitis

263

1.99

5.15

1.2

92.11

95.88

u/l

0.07

220

Other and unspecified drugs and medicaments

196

2.16

5.15

1.2

153.77

85.12

u/l

1.12

167

Other specified/unspecified hearing loss

236

2.05

5.15

1.3

1.2

79.68

88.80

u/l

0.28

203

Disorders of tooth development and eruption

309

1.82

5.12

1.4

1.3

108.71

90.97

u/l

0.36

262

Renal agenesis and other reduction defects of kidney, including avohilmo

13.80

5.12

1.4

1.3

67.25

64.67

u/l

—

Myocardial infarction, with ST-elevation

406

1.78

5.11

1.2

1.3

124.44

97.70

u/l

0.74

329

Malignant neoplasm of kidney, except renal pelvis

171

2.23

5.09

1.3

1.2

82.28

89.24

u/l

0.23

141

Radiculopathy

429

1.76

5.08

1.2

73.86

91.84

u/l

1.33

355

Diseases of oral cavity, salivary glands and jaws

224

824

1.40

5.08

1.2

96.85

96.55

u/l

0.01

187

708

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

229

2.05

5.07

1.3

1.2

94.95

83.45

u/l

0.14

201

Macular hole

140

2.38

5.07

1.2

98.82

85.07

u/l

0.27

123

Other follicular disorders

140

2.37

5.06

1.3

1.2

91.25

88.00

u/l

0.04

122

Other viral diseases, not elsewhere classified

428

1.75

5.06

1.3

1.2

91.80

105.49

u/l

0.46

366

Idiopathic thrombocytopenic purpura

3.31

5.04

1.4

1.1

226.83

87.62

u/l

0.96

Acute pharyngitis

283

1.93

5.03

1.4

1.2

105.83

85.50

u/l

0.31

232

Behavioural syndromes associated with physiological disturbances and physical factors

403

2142

1.27

5.01

1.2

1.3

88.26

92.07

u/l

0.29

340

1851

Iridocyclitis

101

628

1.61

5.01

1.2

105.30

92.09

u/l

0.63

524

Use of pramipexole

106

667

1.60

5.01

1.3

1.2

75.94

89.50

u/l

0.85

565

Carcinoma in situ of skin

219

2.07

4.97

1.1

1.3

99.05

90.15

u/l

0.24

184

COPD, hospital admission 2, with asthma infections

138

791

1.51

4.95

1.1

1.3

109.21

103.64

u/l

0.20

114

658

Fibroblastic disorders

102

638

1.60

4.94

1.3

94.01

95.84

u/l

0.07

537

Infection due to other mycobacteria, including avohilmo

5.50

4.93

1.8

1.2

138.00

74.22

u/l

1.07

Sequelae of injuries of lower limb

213

2.08

4.93

1.2

91.11

85.21

u/l

0.13

180

Follicular cysts of skin and subcutaneous tissue

493

1.69

4.93

1.3

1.2

82.54

94.69

u/l

0.65

412

Alcohol use disorder, ICD-based

160

1104

1.45

4.91

1.2

1.3

109.35

99.43

u/l

0.44

130

942

Single spontaneous delivery

792

0.62

4.91

1.2

1.3

81.54

90.74

u/l

0.39

689

Phlebitis and thrombophlebitis (not including DVT)

616

1.61

4.91

1.2

100.55

87.14

u/l

0.85

515

COPD

192

1107

1.41

4.90

1.2

105.54

93.25

u/l

0.72

160

938

Diseases of spleen

4.62

4.89

1.1

1.2

99.73

74.04

u/l

0.94

Psoriatic arthropathies

234

2.02

4.89

1.3

1.2

65.36

85.71

u/l

1.77

190

Pain in thoracic spine

405

1.76

4.87

1.2

75.22

89.96

u/l

0.80

343

Family history of malignant neoplasm

248

1.98

4.87

1.4

1.2

66.84

82.24

u/l

0.73

215

Sulfonylureas

147

789

1.48

4.87

1.3

132.89

92.23

u/l

2.59

133

655

Superficial injury of abdomen, lower back and pelvis

362

1.80

4.83

1.3

1.2

100.40

87.87

u/l

0.22

299

Disturbances of skin sensation

119

776

1.54

4.83

1.3

1.2

81.10

90.85

u/l

0.65

106

656

Other diseases of lip and oral mucosa

190

1358

1.40

4.82

1.2

78.54

89.48

u/l

1.21

156

1159

Other and unspecified urticaria

504

1.67

4.81

1.3

1.2

92.17

86.82

u/l

0.10

433

Barrett oesophagus

107

2.54

4.80

1.1

91.70

93.71

u/l

0.04

Aortic aneurysm

524

1.65

4.79

1.2

1.3

108.14

98.61

u/l

0.41

433

Unspecified lump in breast

505

1.67

4.79

1.3

1.2

70.42

82.11

u/l

0.85

436

Secondary right heart disease

2.76

4.78

1.3

1.2

151.50

84.88

u/l

1.35

Coxarthrosis

209

970

1.39

4.78

1.3

93.08

102.09

u/l

0.45

183

824

Malignant melanoma of skin, including Hilmo

313

1.86

4.78

1.4

1.2

100.27

84.86

u/l

0.75

258

Erectile dysfunction

170

2.19

4.74

1.3

114.45

103.16

u/l

0.22

142

Subjective visual disturbances

116

756

1.54

4.73

1.2

93.79

87.68

u/l

0.25

644

Hemiplegia

102

2.57

4.71

1.5

1.2

98.33

82.47

u/l

0.39

Other and unspecified injuries of lower leg

164

2.21

4.71

1.2

114.94

79.31

u/l

0.95

139

Superficial injury of hip and thigh

365

1.79

4.71

1.4

1.2

105.23

90.31

u/l

0.52

304

Other viral diseases, not elsewhere classified, including avohilmo

107

681

1.57

4.70

1.3

1.2

85.51

95.87

u/l

0.50

580

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

317

1.79

4.66

1.3

1.2

75.58

103.62

u/l

0.80

269

Acute and subacute iridocyclitis

509

1.66

4.65

1.2

106.14

91.46

u/l

0.69

427

Hyperaldosteronism

3.14

4.65

1.2

84.31

82.96

u/l

0.03

Adverse effects, not elsewhere classified

509

1.66

4.65

1.3

1.2

91.13

86.52

u/l

0.10

440

Injuries to the shoulder and upper arm

369

2241

1.27

4.65

1.3

99.78

92.59

u/l

0.52

316

1933

Ingrowing nail

109

2.49

4.63

1.5

1.2

93.89

84.01

u/l

0.19

Hereditary hypogammaglobulinemia

14.66

4.63

1.1

1.4

120.86

56.20

u/l

—

Delivery, wide proxy

638

0.59

4.62

1.3

1.2

72.10

89.32

u/l

2.08

556

Malignant neoplasm of urinary organs

185

2.12

4.62

1.3

1.2

81.27

90.22

u/l

0.33

150

COPD related to multimorbidity

166

983

1.43

4.61

1.1

1.3

106.55

101.45

u/l

0.21

138

822

Unspecific neurodegenerative disorder

987

0.63

4.59

1.1

1.2

83.13

97.91

u/l

0.84

838

Other chronic obstructive pulmonary disease

184

1076

1.40

4.56

1.2

106.87

93.66

u/l

0.75

153

910

Intracranial injury

239

1664

1.34

4.56

1.2

102.69

92.93

u/l

0.55

198

1436

Other diseases of the respiratory system

528

1.63

4.53

1.4

1.2

131.64

97.62

u/l

1.01

439

Other respiratory disorders and diseases

528

1.63

4.53

1.4

1.2

131.64

97.62

u/l

1.01

439

Dermatophytosis, including avohilmo

269

2007

1.31

4.53

1.2

1.3

85.69

93.82

u/l

0.83

236

1712

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

147

1004

1.45

4.48

1.3

1.2

79.35

89.28

u/l

0.92

128

857

Other pulmonary heart/vessel disease

2.55

4.47

1.3

1.2

152.25

90.51

u/l

1.35

Pneumonia derived septicemia

2.95

4.45

1.5

1.2

279.58

78.16

u/l

0.51

Anterior Iridocyclitis

554

1.61

4.45

1.2

106.03

90.92

u/l

0.75

469

Arthropathic psoriasis

278

1.88

4.44

1.3

1.2

72.72

92.94

u/l

0.97

230

Other enthesopathy of foot (+metatarsalgia)

271

1.89

4.43

1.3

1.2

95.07

85.23

u/l

0.24

238

Symptoms and signs involving speech and voice

152

1062

1.44

4.42

1.3

1.2

82.80

89.61

u/l

0.44

132

897

Arthrosis

270

1118

1.32

4.40

1.2

1.3

92.32

101.89

u/l

0.57

236

948

Melanoma in situ

106

2.47

4.39

1.2

111.90

87.89

u/l

0.64

Symptoms and signs involving the nervous and musculoskeletal systems

246

1860

1.32

4.38

1.3

1.2

104.51

92.47

u/l

0.52

205

1593

Early onset COPD

611

1.58

4.38

1.2

1.3

112.07

94.82

u/l

0.59

510

Melanocytic naevi of trunk

287

1.85

4.35

1.2

98.84

86.90

u/l

0.34

245

Malignant neoplasm of oral cavity, including Hilmo

2.75

4.35

1.2

1.1

102.13

87.83

u/l

0.22

Other blood glucose lowering drugs, excl. Insulins

443

1.68

4.32

1.2

83.04

92.17

u/l

0.33

368

Atrophic disorders of skin

474

1.65

4.31

1.2

92.39

81.82

u/l

0.19

406

Fracture of foot, except ankle

102

661

1.55

4.30

1.4

1.2

99.29

85.89

u/l

0.54

566

Progressive vascular leukoencephalopathy

2.55

4.30

1.2

72.47

90.23

u/l

0.66

Somatoform disorder

429

1.68

4.28

1.3

1.2

86.95

86.71

u/l

0.01

369

Bipolar affective disorders

429

1.68

4.28

1.2

113.45

84.79

u/l

1.22

362

Fenamates

272

1.73

4.26

1.1

1.3

85.20

105.39

u/l

0.90

241

Faecal incontinence

261

1.89

4.25

1.3

1.2

86.03

84.27

u/l

0.05

217

Diseases of salivary glands

143

996

1.44

4.25

1.3

1.2

81.13

89.95

u/l

0.68

126

843

Other and unspecified visual disturbances

254

1.90

4.24

1.1

1.2

97.37

86.25

u/l

0.32

215

Metatarsalgia

247

1.91

4.24

1.3

1.2

93.10

85.31

u/l

0.16

216

Episodal and paroxysmal disorders

449

1842

1.24

4.22

1.2

1.3

91.42

97.57

u/l

0.49

373

1598

Autoimmune hyperthyroidism

108

2.42

4.22

1.2

1.1

64.76

82.57

u/l

0.57

Anorexia (incl.atypical)

2.57

4.21

1.2

79.24

81.76

u/l

0.04

134

791

1.46

4.19

1.3

1.2

104.90

91.95

u/l

0.72

107

670

Diseases of pulp and periapical tissues and dental caries

261

1013

1.32

4.19

1.2

100.59

99.00

u/l

0.06

221

868

Sleep apnoea

403

2041

1.25

4.18

1.2

1.3

78.36

97.26

u/l

4.46

343

1756

Chondrocostal junction syndrome [Tietze]

2.68

4.16

1.3

1.2

110.86

80.65

u/l

0.69

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

100

642

1.54

4.16

1.2

109.94

84.82

u/l

0.99

555

Other disorders of the musculoskeletal system and connective tissue

395

1.70

4.16

1.3

1.2

83.48

91.13

u/l

0.34

334

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

6.02

4.16

1.2

1.3

458.90

78.42

u/l

—

Other disorders of iris and ciliary body

3.11

4.09

1.4

1.2

97.19

83.07

u/l

0.49

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

133

922

1.45

4.07

1.2

1.3

86.88

87.79

u/l

0.04

119

775

Glucagon-like peptide-1 (GLP-1) analogues

133

922

1.45

4.07

1.2

1.3

86.88

87.79

u/l

0.04

119

775

Localized swelling, mass and lump of skin and subcutaneous tissue

137

955

1.44

4.07

1.2

1.3

96.20

92.69

u/l

0.14

121

799

Poisoning by drugs, medicaments and biological substances

607

1.55

4.06

1.2

112.19

86.74

u/l

1.38

521

Pregnancy, childbirth and the puerperium

540

0.59

4.04

1.3

1.2

79.00

89.62

u/l

0.87

469

Poisoning by medicine

537

1.59

4.03

1.2

113.12

88.02

u/l

1.16

460

Other inflammation of eyelid

414

1.67

4.03

1.4

1.2

95.12

83.94

u/l

0.19

355

Ocular pain

189

2.02

4.02

1.2

65.60

82.44

u/l

0.88

165

Haemorrhoids and perianal venous thrombosis

131

901

1.45

4.02

1.3

1.2

91.61

89.04

u/l

0.08

114

764

Conjunctivitis (acute, non atopic)

117

790

1.48

4.01

1.2

89.51

90.15

u/l

0.02

105

669

Gonarthrosis [arthrosis of knee](FG)

289

1290

1.29

3.98

1.2

1.3

88.39

98.78

u/l

0.89

244

1108

COPD, hospital admissions

184

1138

1.36

3.95

1.2

1.3

106.87

99.45

u/l

0.34

153

952

Other inflammation of eyelid, including avohilmo

185

1365

1.36

3.95

1.3

89.99

88.28

u/l

0.06

163

1166

Single delivery by forceps and vacuum extractor

253

0.38

3.94

1.1

1.3

59.81

101.61

u/l

3.85

226

Enthesopathies of lower limb, excluding foot

636

1.53

3.92

1.3

87.59

93.68

u/l

0.24

536

Other skin changes

565

1.56

3.91

1.2

90.00

94.81

u/l

0.19

475

Superficial injury of lower leg

109

733

1.49

3.91

1.3

1.2

91.27

90.78

u/l

0.01

627

Hyphaema and other vascular disorders of iris and ciliary body

3.83

3.90

1.4

1.3

101.00

83.29

u/l

0.57

Infections with a predominantly sexual mode of transmission

112

756

1.48

3.90

1.2

103.68

83.83

u/l

0.91

652

Other congenital malformations, including avohilmo

276

1.82

3.90

1.3

1.2

89.76

84.56

u/l

0.12

240

Colonic or urogenital fistula

114

776

1.47

3.86

1.1

1.2

82.45

92.81

u/l

0.65

101

648

Amputation of thigh

2.99

3.85

1.7

1.2

153.19

110.16

u/l

0.68

Congenital malformations of genital organs

171

2.04

3.83

1.1

1.2

110.17

78.65

u/l

0.32

151

Multiple myeloma and malignant plasma cell neoplasms

114

2.30

3.78

1.5

1.2

129.88

92.26

u/l

0.65

Bacterial, viral and other infectious agents, including avohilmo

180

2.01

3.78

1.3

1.2

98.97

92.39

u/l

0.13

155

Other infective otitis externa

127

2.22

3.76

1.3

1.2

70.68

80.57

u/l

0.45

108

Corneal ulcer

484

1.60

3.76

1.5

1.2

93.00

93.32

u/l

0.01

408

Alcohol dependence

643

1.51

3.75

1.1

1.3

117.31

103.57

u/l

0.42

539

Other chronic obstructive pulmonary disease, including avohilmo

225

1410

1.31

3.74

1.2

1.3

101.35

97.20

u/l

0.21

189

1201

COPD, early/later onset

184

1146

1.35

3.72

1.2

106.87

99.49

u/l

0.34

153

960

Epilepsy

125

870

1.44

3.72

1.2

1.3

127.95

97.85

u/l

1.16

104

748

Alcohol-induced chronic pancreatitis

141

2.14

3.71

1.2

128.76

96.30

u/l

0.62

118

Benign neoplasm: Ascending colon

386

1.66

3.70

1.2

128.37

86.74

u/l

1.31

325

Other disorders of cornea

231

1.87

3.68

1.1

1.2

94.35

85.41

u/l

0.24

198

Sequelae of cerebrovascular disease

148

908

1.39

3.68

1.2

126.38

94.87

u/l

1.25

121

762

Complications of the puerperium, not elsewhere classified

2.87

3.63

1.4

1.1

72.06

80.51

u/l

0.20

Seborrhoeic dermatitis

225

1.87

3.63

1.5

1.2

72.94

93.98

u/l

1.44

186

Hypothyroidism, strict autoimmune, 3 medication purchases required

344

1860

1.24

3.63

1.2

1.3

84.01

93.45

u/l

1.25

302

1582

L02BB Anti-androgens

183

1.98

3.62

2.7

1.2

89.48

116.65

u/l

0.60

148

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

351

1.69

3.59

1.3

1.2

119.78

84.04

u/l

1.26

292

Other diseases of oesophagus

191

1.94

3.57

1.4

1.1

60.53

83.74

u/l

1.67

158

Substance use, excluding alcohol

483

1.58

3.57

1.2

105.05

93.64

u/l

0.43

411

Thyrotoxicosis with diffuse goitre

375

1.66

3.55

1.2

73.76

85.50

u/l

0.52

321

Other enthesopathies

124

874

1.42

3.52

1.3

1.2

94.89

92.79

u/l

0.07

104

743

Toxic effect of alcohol

3.65

3.50

1.0

1.3

75.50

79.13

u/l

—

Sleep apnoea, including avohilmo

416

2070

1.22

3.50

1.2

1.3

78.30

96.71

u/l

4.11

352

1784

Palmar fascial fibromatosis [Dupuytren]

354

1.67

3.49

1.4

1.3

101.12

102.15

u/l

0.02

288

Bacterial, viral and other infectious agents

165

2.01

3.49

1.3

1.2

101.33

90.02

u/l

0.23

142

Lung diseases due to external agents

311

1.71

3.41

1.2

117.55

97.93

u/l

0.51

258

Rotator cuff syndrome

244

1310

1.28

3.40

1.3

91.69

96.90

u/l

0.32

208

1125

Nonsuppurative otitis media, including avohilmo

114

687

1.44

3.39

1.3

1.2

82.14

86.54

u/l

0.16

101

588

Otitis externa

626

1.49

3.38

1.4

1.2

91.63

89.78

u/l

0.06

534

Carpal tunnel syndrome

260

1779

1.27

3.38

1.3

1.2

74.81

92.87

u/l

3.61

229

1519

Other and unspecified vascular occlusions

225

1.83

3.32

1.2

99.44

92.25

u/l

0.18

193

Malignant neoplasm of head and neck

148

2.03

3.30

1.2

130.83

92.52

u/l

0.58

121

Psoriatic arthropathies, ICD10

270

1.75

3.28

1.3

1.2

65.36

90.73

u/l

2.22

226

Umbilical hernia

680

1.46

3.27

1.3

115.84

96.79

u/l

0.76

572

D07AA Corticosteroids, weak (group I)

345

1.65

3.26

1.1

1.2

93.48

102.37

u/l

0.22

293

Dementia

105

1024

0.70

3.26

1.2

93.22

96.05

u/l

0.08

860

Appendectomy

253

1908

1.26

3.25

1.3

102.76

90.20

u/l

1.00

223

1632

Complications of labour and delivery

168

1240

0.75

3.25

1.2

78.54

84.18

u/l

0.34

148

1075

Sleep disorders

371

2101

1.22

3.24

1.2

1.3

84.38

91.47

u/l

0.69

309

1817

Ganglion

576

1.50

3.22

1.3

1.2

77.11

90.89

u/l

1.08

488

Carcinoma in situ of skin of ear and external auricular canal

3.58

3.21

1.0

1.2

88.08

104.14

u/l

0.25

Disease of hard tissues of teeth, NOS

201

802

1.31

3.19

1.2

84.09

95.46

u/l

1.04

166

690

Hallux rigidus

389

1.60

3.12

1.2

1.3

83.14

86.31

u/l

0.12

325

Other diseases of upper respiratory tract

449

1959

1.19

3.12

1.3

1.2

86.66

99.24

u/l

1.71

384

1679

Gonarthrosis

240

1064

1.28

3.12

1.2

1.3

89.45

101.70

u/l

0.95

204

907

Fracture at wrist and hand level

134

977

1.37

3.11

1.2

79.82

91.69

u/l

0.57

113

827

Traumatic subdural haemorrhage

306

1.66

3.09

1.3

110.53

102.08

u/l

0.21

249

Dementia, including avohilmo

115

1090

0.72

3.08

1.2

92.18

95.89

u/l

0.11

917

Other disorders of optic [2nd] nerve and visual pathways

132

2.06

3.06

1.3

1.2

104.52

82.23

u/l

0.46

116

Other neurological diseases

298

1874

1.23

3.06

1.2

94.27

94.79

u/l

0.03

259

1597

Sequelae of injuries, of poisoning and of other consequences of external causes

649

1.45

3.05

1.2

79.81

91.33

u/l

0.59

550

Spondylolisthesis/Spondylolysis

527

1.50

3.04

1.4

1.2

75.41

87.09

u/l

0.74

443

Other and unspecified effects of external causes

104

733

1.42

3.02

1.3

1.2

87.33

89.94

u/l

0.07

626

Rheumatic fever with heart involvement

10.23

2.99

1.6

65.60

72.80

u/l

—

Viral warts

211

1.81

2.99

1.3

1.2

70.29

87.15

u/l

1.30

178

Acne

167

1.91

2.99

1.3

1.2

60.24

86.17

u/l

1.61

145

Disorders of optic nerve and visual pathways

212

1.80

2.95

1.2

99.43

85.88

u/l

0.36

185

Polyarthrosis

580

1.45

2.94

1.2

94.19

91.54

u/l

0.09

494

Ptosis of eyelid

303

1.66

2.91

1.2

105.57

81.45

u/l

0.89

255

Postpartum haemorrhage

540

0.58

2.90

1.3

1.2

72.52

89.52

u/l

0.66

472

Abnormal findings in secretions and smears from cervix uteri vagina vulva

195

1115

1.29

2.89

1.2

74.10

84.20

u/l

1.06

167

973

Fall on and from stairs and steps

109

782

1.40

2.88

1.3

1.2

107.92

90.05

u/l

0.81

657

Pneumonia due to Streptococcus pneumoniae

2.44

2.88

1.6

1.2

111.24

79.52

u/l

0.39

Other endocrine disorders

2.22

2.87

1.3

1.1

235.81

99.08

u/l

0.35

Adhesive capsulitis of shoulder

478

1.51

2.86

1.1

1.2

87.92

92.14

u/l

0.15

399

Thoracic aortic aneurysm

328

1.62

2.85

1.2

1.3

100.60

89.47

u/l

0.37

268

Other mental disorders due to brain damage and dysfunction and to physical disease

305

1.65

2.85

1.3

1.2

96.42

95.35

u/l

0.03

256

Other and unspecified follicular disorders

2.30

2.84

1.2

71.27

91.47

u/l

0.61

Mouth breathing

150

1133

1.32

2.83

1.2

1.3

90.34

99.13

u/l

0.41

129

962

Atopic dermatitis, strict definition with reimbursement

105

721

1.40

2.82

1.2

107.14

84.33

u/l

0.67

623

Other noninfective disorders of lymphatic vessels and lymph nodes

2.35

2.82

1.4

1.2

68.94

78.67

u/l

0.22

Other specified disorders of kidney and ureter

2.41

2.80

1.1

1.2

277.35

80.68

u/l

0.43

severe traumatic brain injury, does not include concussion

562

1.46

2.79

1.3

1.2

100.97

97.03

u/l

0.13

463

Infections with a predominantly sexual mode of transmission, including avohilmo

138

944

1.34

2.79

1.2

103.09

85.14

u/l

0.94

116

820

Other crystal arthropathies

3.60

2.79

1.2

1.1

57.20

91.33

u/l

—

Nummular dermatitis

187

1.83

2.78

1.5

1.2

104.04

87.62

u/l

0.31

155

Malignant neoplasm of head and neck, including Hilmo

187

1.82

2.78

1.2

122.31

92.83

u/l

0.48

155

Other superficial mycoses

3.10

2.77

1.6

1.1

52.83

73.29

u/l

0.86

Dental operations

237

969

1.26

2.77

1.2

103.05

97.73

u/l

0.24

193

833

Anogenital herpesviral [herpes simplex] infection, including avohilmo

202

1.79

2.76

1.2

72.55

80.72

u/l

0.28

177

Problems related to lifestyle

173

1.85

2.76

1.2

104.17

82.42

u/l

0.44

145

Mixed conductive and sensorineural hearing loss

339

1.60

2.76

1.3

1.2

87.30

88.49

u/l

0.03

286

COPD-related respiratory insufficiency

285

1.65

2.75

1.1

1.2

113.68

95.93

u/l

0.37

241

Redundant prepuce, phimosis and paraphimosis

451

1.51

2.74

1.5

1.3

92.34

103.50

u/l

0.39

380

Maternal care for known or suspected malpresentation of fetus

284

0.48

2.74

1.5

1.2

68.47

88.39

u/l

0.66

252

Other psoriatic arthropathies

255

1.69

2.73

1.3

1.2

67.26

90.92

u/l

1.81

212

Use of donepezil

587

0.58

2.72

1.1

1.2

82.81

96.63

u/l

0.51

493

Cervicalgia

574

1.45

2.71

1.3

1.2

72.27

90.72

u/l

1.64

482

Nonspecific lymphadenitis

125

2.01

2.70

1.3

1.2

88.67

80.48

u/l

0.21

104

False labour

492

0.63

2.69

1.2

68.02

87.31

u/l

2.26

436

606

1.42

2.67

1.3

1.2

103.69

90.83

u/l

0.52

509

Premature rupture of membranes

365

0.54

2.66

1.4

1.2

129.48

84.96

u/l

0.50

327

Disorders of breast

210

1471

1.26

2.66

1.3

1.2

74.43

85.80

u/l

1.14

188

1276

Maternal care for other conditions predominantly related to pregnancy

490

1.48

2.64

1.2

78.81

83.77

u/l

0.32

425

Colon adenocarcinoma

258

1.67

2.63

1.1

1.2

123.86

83.23

u/l

0.99

211

Insomnia

361

2109

1.19

2.62

1.2

1.3

84.53

91.14

u/l

0.62

298

1822

Special screening examination for other diseases and disorders

243

1.69

2.61

1.4

1.2

167.25

81.09

u/l

1.24

201

Post-traumatic stress disorder

113

2.04

2.61

1.3

1.2

68.33

83.36

u/l

0.43

Acute and transient psychotic disorders

274

1.65

2.61

1.1

1.2

82.24

86.77

u/l

0.14

231

Malignant neoplasm of colon

344

1.57

2.61

1.1

1.2

203.02

84.52

u/l

0.85

284

Occupational exposure to risk-factors

0.00

2.60

0.0

1.2

—

88.20

—

Malignant neoplasm of colon, including Hilmo

414

1.52

2.60

1.1

1.2

184.26

87.93

u/l

0.77

350

Missing teeth due to accident, extraction or parodontitis

260

1898

1.22

2.60

1.2

1.3

88.50

94.22

u/l

0.48

219

1629

Status post-ami

468

1.43

2.58

1.2

1.3

129.46

95.06

u/l

1.24

396

Benign thyroid growths and nodules

143

1013

1.31

2.57

1.3

1.2

75.53

90.41

u/l

1.23

120

858

Injuries to the wrist and hand

405

2283

1.18

2.54

1.3

89.97

94.36

u/l

0.35

352

1962

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

223

1.71

2.53

1.4

1.2

80.63

82.78

u/l

0.06

187

Ovarian cyst

147

639

1.32

2.52

1.2

1.3

84.67

89.47

u/l

0.30

126

544

Raynaud syndrome

194

1.76

2.50

1.2

131.96

82.68

u/l

0.54

170

Pneumococcal septicemia

2.33

2.49

1.5

1.2

92.75

77.75

u/l

0.20

174

1232

1.27

2.46

1.2

95.09

95.96

u/l

0.04

144

1040

Pure hyperglyceridaemia

2.69

2.45

1.3

1.2

58.42

85.23

u/l

1.21

Other headache syndromes

167

1307

1.28

2.44

1.3

79.62

90.88

u/l

1.05

146

1130

Crystal arthropathies, rheuma endpoint

3.15

2.44

1.2

1.1

57.20

77.33

u/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

100

733

1.37

2.39

1.2

109.94

85.95

u/l

0.93

628

LSIL lesion of the cervix uteri, vagina or vulva

329

1.55

2.37

1.2

77.86

81.78

u/l

0.14

285

Aggressive periodontitis

2.52

2.36

1.2

73.92

81.27

u/l

0.22

Other abnormal products of conception

573

0.67

2.34

1.3

1.2

71.91

82.76

u/l

0.55

494

Follow-up examination after treatment for malignant neoplasms

244

1.64

2.33

1.3

1.2

94.00

86.08

u/l

0.18

206

Sensorineural hearing loss

224

1824

0.82

2.31

1.3

1.2

92.77

96.52

u/l

0.17

198

1564

Unspecified mental disorder

147

1146

1.28

2.30

1.1

1.3

79.41

89.22

u/l

0.95

128

979

Use of other anti-dementia drugs

678

0.68

2.29

1.1

1.2

91.31

100.16

u/l

0.26

568

Use of memantine

678

0.68

2.29

1.1

1.2

91.31

100.16

u/l

0.26

568

Extreme obesity with alveolar hypoventilation

2.13

2.29

1.3

1.2

82.83

81.45

u/l

0.03

Burns and corrosions

316

1.55

2.29

1.3

1.2

117.70

92.80

u/l

0.32

260

Artificial joint re-operation

170

1.77

2.28

1.1

1.2

78.16

83.27

u/l

0.17

147

Benign neoplasm of eye and adnexa

269

1.60

2.28

1.2

117.76

86.74

u/l

0.40

229

Plantar fascial fibromatosis

269

1.60

2.28

1.2

77.79

81.71

u/l

0.14

236

Dislocation, sprain and strain of joints and ligaments of thorax

2.24

2.28

1.3

1.2

75.94

81.56

u/l

0.18

Somnolence, stupor and coma

2.08

2.27

1.3

1.2

100.64

94.80

u/l

0.08

Maternal care related to the fetus and amniotic cavity and possible delivery problems

109

848

0.75

2.23

1.2

77.30

84.42

u/l

0.37

748

Suicide or other Intentional self-harm

633

1.38

2.21

1.2

113.55

88.34

u/l

0.88

541

Acne vulgaris

121

1.90

2.19

1.2

56.06

89.28

u/l

2.27

109

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

643

1.37

2.19

1.2

83.81

85.04

u/l

0.04

550

Other specified congenital malformation syndromes affecting multiple systems

3.36

2.18

1.3

47.38

91.63

u/l

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

377

1.49

2.16

1.2

98.65

89.58

u/l

0.30

322

Necrosis of pulp, including avohilmo

216

1752

1.22

2.16

1.2

1.3

83.78

91.45

u/l

0.79

186

1500

Cervicocranial syndrome

273

1.58

2.16

1.5

1.2

76.30

88.89

u/l

0.49

230

Toxic effect of ethanol

2.31

2.15

1.0

1.2

109.86

91.21

u/l

—

Nontoxic diffuse goitre

2.22

2.11

1.2

1.1

51.80

75.18

u/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.37

2.11

1.3

1.2

55.69

82.45

u/l

1.02

Assault

267

1.58

2.11

1.3

1.2

113.83

95.04

u/l

0.46

227

Atopic dermatitis, strict definition

718

1.34

2.07

1.2

96.55

82.00

u/l

0.41

623

Autism spe, excluding more controls

2.91

2.07

1.6

1.1

72.67

77.58

u/l

—

Restless leg syndrome

398

1.46

2.06

1.1

1.2

60.31

90.54

u/l

4.21

340

Diseases of external ear

137

1078

1.27

2.04

1.3

1.2

83.97

92.55

u/l

0.58

117

903

Other and unspecified disorders of vitreous body

183

1455

1.23

2.04

1.3

1.2

71.24

89.20

u/l

3.47

154

1243

Alzheimer disease, including avohilmo

850

0.75

2.03

1.1

1.2

82.53

99.28

u/l

0.97

720

Postpartum hemorraghe, all women as controls

577

0.64

2.03

1.3

1.2

72.52

85.40

u/l

0.46

507

Granulomatous disorders of skin and subcutaneous tissue

2.42

2.03

1.7

1.1

121.25

81.00

u/l

0.50

Non-Hodgkin lymphoma, all

2.11

2.02

1.4

1.1

182.62

93.52

u/l

1.20

Peroneal tendinitis

3.10

2.02

1.1

1.2

73.50

69.19

u/l

—

Other specified/unspecified deforming dorsopathies

3.10

2.02

1.0

1.2

83.88

78.95

u/l

—

Colorectal cancer

552

1.37

2.01

1.2

161.44

86.89

u/l

0.77

467

Wide developmental disorders, excluding more controls

2.65

2.00

1.5

1.1

72.10

186.71

u/l

—

Migraine with aura

671

1.34

1.98

1.4

1.2

86.12

87.65

u/l

0.06

581

Foreign body in alimentary tract

112

1.88

1.96

1.2

94.27

100.13

u/l

0.12

Other and unspecified haemorrhagic conditions

2.99

1.94

1.4

1.3

90.38

72.36

u/l

—

Other disorders of nervous system

157

1.73

1.92

1.6

1.2

68.45

85.30

u/l

0.81

134

Unspecified dementia

229

0.47

1.91

1.2

1.1

97.17

101.86

u/l

0.08

193

Disorders of psychological development

195

1.62

1.91

1.3

1.2

88.33

100.45

u/l

0.17

177

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

222

1436

1.20

1.90

1.2

1.3

81.32

87.37

u/l

0.51

193

1231

Acne, including avohilmo

319

1.45

1.90

1.3

65.93

85.03

u/l

1.14

278

Other and unspecified nerve root and plexus disorders, also in other diseases

605

0.66

1.89

1.2

86.22

89.77

u/l

0.09

506

Other hammer toe(s) (acquired)

475

1.38

1.88

1.2

87.04

89.70

u/l

0.13

405

Other and unspecified rosacea

228

1.58

1.87

1.3

1.2

72.13

81.68

u/l

0.52

193

Portal vein thrombosis

2.67

1.87

1.6

1.2

112.33

81.17

u/l

—

Graves disease, strict definition

252

1.55

1.86

1.2

78.00

86.26

u/l

0.21

219

Other congenital malformations of skin, including avohilmo

182

1.65

1.84

1.2

81.36

82.45

u/l

0.04

158

Other hearing loss

119

904

1.28

1.84

1.2

91.32

99.69

u/l

0.39

100

761

Skin changes due to chronic exposure to nonionizing radiation

160

1175

1.23

1.84

1.2

95.86

96.22

u/l

0.01

131

992

Otitis externa, unspecified

253

1.55

1.83

1.3

1.2

97.79

82.70

u/l

0.34

218

Injury of eye and orbit

302

1.49

1.81

1.3

1.2

100.51

90.07

u/l

0.29

257

Colorectal cancer, including Hilmo

611

1.33

1.81

1.2

153.64

88.08

u/l

0.73

517

Adult respiratory distress syndrome

3.07

1.80

1.0

1.2

121.57

82.94

u/l

—

Paracetamol or NSAID medication

165

1.50

1.80

1.2

72.79

98.46

u/l

0.91

145

Autism spe

2.58

1.80

1.6

1.2

72.67

68.25

u/l

—

Alzheimer disease

737

0.75

1.79

1.1

1.2

84.66

99.10

u/l

0.66

624

Superficial injury of shoulder and upper arm

287

1.50

1.78

1.3

1.2

100.46

92.16

u/l

0.11

244

Toxic effects of substances chiefly nonmedicinal as to source

231

1.56

1.78

1.1

1.2

91.00

94.88

u/l

0.07

194

LSIL lesion of the cervix uteri

231

1.56

1.78

1.2

74.52

81.26

u/l

0.25

203

Actinic keratosis

155

1145

1.23

1.78

1.3

1.2

97.17

96.19

u/l

0.04

127

966

Contact with sharp glass

2.18

1.78

1.3

1.2

61.00

90.00

u/l

1.13

Spirochaetal infections, other/unspecified

208

1.59

1.76

1.2

83.14

84.06

u/l

0.02

178

Presence of other functional implants

221

1270

1.19

1.75

1.3

1.2

111.37

88.26

u/l

1.75

195

1071

Autism

2.51

1.74

1.6

1.2

72.67

69.17

u/l

—

Scabies, including avohilmo

314

1.47

1.72

1.2

68.39

83.26

u/l

0.82

271

Foreign body entering into or through eye or natural orifice

163

1.66

1.71

1.7

1.2

75.05

94.43

u/l

0.84

137

Benign neoplasm of male genital organs

0.00

1.70

0.0

1.2

—

79.29

—

Benign neoplasm of breast

341

1.44

1.68

1.2

72.39

78.14

u/l

0.36

293

Carcinoma in situ of breast, intraductal

268

1.50

1.66

1.3

1.2

76.77

87.56

u/l

0.30

231

Transient ischemic attack

202

1350

1.19

1.66

1.2

100.76

91.07

u/l

0.49

173

1153

Deficiency of other B group vitamins

2.46

1.64

1.3

1.2

77.20

74.86

u/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

220

1.55

1.64

1.3

1.2

151.10

85.19

u/l

0.76

181

Disorders of muscles

228

1.54

1.64

1.4

1.2

65.07

82.44

u/l

1.02

192

Persons encountering health services in other circumstances

133

1064

1.24

1.63

1.4

1.2

107.43

87.78

u/l

1.26

117

896

Periapical abscess

173

1438

1.20

1.63

1.3

85.20

92.21

u/l

0.41

147

1223

Nonsuppurative otitis media

421

1.36

1.62

1.4

1.2

109.42

86.76

u/l

0.38

357

Superficial injury of wrist and hand

530

1.34

1.62

1.2

78.25

89.25

u/l

0.72

455

Recurrent dislocation of patella

2.15

1.61

1.2

1.1

88.00

91.00

u/l

0.05

Cysts of oral region, not elsewhere classified

113

1.78

1.60

1.3

1.2

121.73

89.99

u/l

0.38

Oter anti-inflammatory and antirheumatic agents, non-steroids

335

1.33

1.60

1.2

83.54

107.69

u/l

1.42

294

Disorders of ocular muscles, binocular movement, accommodation and refraction

171

1411

1.20

1.58

1.3

101.21

91.68

u/l

0.35

147

1196

Female genital prolapse

588

0.76

1.57

1.1

1.2

69.57

91.96

u/l

2.26

497

Migraine with aura and triptan purchases

388

1.39

1.57

1.4

1.2

83.62

80.51

u/l

0.12

338

Dental pulpitis, including avohilmo

337

1892

1.14

1.55

1.2

1.3

85.57

91.15

u/l

0.54

279

1630

Schizophrenia or delusion, excluding more controls

752

1.27

1.55

1.1

1.3

73.52

87.73

u/l

1.27

650

Benign neoplasm of urinary organs

107

1.78

1.54

1.5

1.2

94.47

82.64

u/l

0.45

Other symptoms and signs involving the urinary system

240

1.50

1.54

1.3

1.2

122.81

90.45

u/l

0.77

203

Diplopia

314

1.44

1.54

1.4

1.2

92.05

88.62

u/l

0.08

263

Myocardial infarction, unclassifiable

493

1.32

1.52

1.2

116.52

105.49

u/l

0.27

410

Suppurative otitis media, unspecified

0.00

1.52

0.0

1.3

—

83.97

—

Polypectomy (DHB20)

138

1.67

1.51

1.3

1.2

130.65

95.88

u/l

0.46

116

Other disorders of the genitourinary system

400

1.38

1.50

1.3

1.2

75.21

88.62

u/l

0.54

341

Suggestive for eosinophilic asthma

218

1.52

1.48

1.2

120.46

84.20

u/l

0.70

179

Other and unspecified acute skin changes due to ultraviolet radiation

2.13

1.44

1.2

80.00

77.98

u/l

0.05

Seborrhoeic keratosis

761

1.26

1.44

1.4

1.2

86.93

87.55

u/l

0.02

641

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.93

1.44

1.3

1.2

115.29

74.10

u/l

0.92

Meniscus derangement

189

1060

1.18

1.44

1.2

1.3

76.31

101.48

u/l

5.11

159

903

Other bullous disorders

2.05

1.44

1.3

1.2

90.08

76.92

u/l

0.27

Acute suppurative otitis media

512

1.31

1.43

1.4

1.2

73.40

82.74

u/l

0.48

438

Other and unspecified nonorganic psychotic disorders

455

1.34

1.43

1.1

1.2

75.68

89.82

u/l

0.80

392

Familial hypercholesterolemia

319

1.41

1.43

1.2

1.3

99.59

93.46

u/l

0.17

259

Other fall from one level to another

542

1.31

1.42

1.4

1.2

76.79

92.46

u/l

1.19

453

Abrasion of teeth

141

1169

1.21

1.41

1.2

1.3

90.98

85.36

u/l

0.18

121

995

Other disorders of amniotic fluid and membranes

291

0.60

1.40

1.1

1.2

106.72

83.51

u/l

0.50

259

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

139

0.43

1.39

1.7

1.2

45.33

94.80

u/l

—

123

Other specified and unspecified retinal disorders

1.90

1.39

1.2

91.79

77.10

u/l

0.22

Postpartum hemorraghe, parous women as controls

453

0.70

1.39

1.3

1.2

72.52

78.09

u/l

0.17

395

Other and unspecified tonsillitis

583

1.27

1.38

1.2

87.41

85.65

u/l

0.07

489

Intracranial and intraspinal abscess and granuloma

2.63

1.37

1.5

1.2

138.67

85.67

u/l

—

Acute epiglottitis

2.62

1.37

1.2

1.3

118.67

62.06

u/l

—

Conductive and sensorineural hearing loss

249

1894

0.87

1.35

1.3

1.2

90.46

96.19

u/l

0.31

220

1626

Other infestations, including avohilmo

0.00

1.34

0.0

1.2

—

73.67

—

Focal epilepsy

556

1.30

1.34

1.2

140.50

90.82

u/l

1.42

470

Acute nasopharyngitis (common cold)

238

1.46

1.34

1.3

1.2

84.63

90.66

u/l

0.13

195

Other symptoms and signs involving the circulatory and respiratory systems

120

1.67

1.34

1.3

1.2

103.00

86.68

u/l

0.26

Kela-code for severe mental illness

123

1013

1.22

1.33

1.1

1.3

80.91

90.94

u/l

0.82

107

865

COPD, hospital admissions 1, only main diagnosis

122

861

1.22

1.33

1.2

1.3

103.15

101.77

u/l

0.04

100

717

Abnormal involuntary movements

358

1.37

1.33

1.4

1.2

78.52

92.37

u/l

0.55

304

Wet age-related macular degeneration

478

1.31

1.33

1.4

1.2

114.08

92.76

u/l

0.89

400

Hyperplasia of prostate

107

485

1.24

1.32

1.3

133.66

112.82

u/l

0.54

413

Colorectal adenocarcinoma

456

1.32

1.31

1.2

111.56

90.47

u/l

0.62

383

Retinal breaks without detachment

463

1.32

1.30

1.4

1.2

82.86

89.12

u/l

0.25

394

Degenerative diseases of the nervous system

840

0.80

1.30

1.2

85.23

97.92

u/l

0.68

709

Aortic valve malfunction, age under 60 years

209

1.49

1.30

1.3

1.2

101.19

85.89

u/l

0.39

172

Attention to artificial openings

1.85

1.30

1.6

1.2

129.00

109.02

u/l

0.24

Excessive attrition of teeth

217

1862

1.15

1.29

1.3

94.43

89.89

u/l

0.17

188

1594

Heartburn

276

1.42

1.28

1.3

1.2

80.71

85.68

u/l

0.15

229

Hallux valgus (acquired)

123

725

1.21

1.27

1.2

77.31

89.77

u/l

1.23

111

619

Familial hypercholesterolemia, with ischemic heart disease

202

1.49

1.27

1.1

1.3

112.28

88.24

u/l

0.64

167

Pediculosis, acariasis and other infestations, including avohilmo

388

1.34

1.25

1.2

71.32

84.80

u/l

0.67

333

Diseases of inner ear

212

1761

1.15

1.25

1.2

85.58

93.20

u/l

0.50

183

1499

Rosacea

337

1.37

1.24

1.3

1.2

77.60

84.80

u/l

0.31

292

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

804

1.23

1.24

1.3

1.2

92.32

90.18

u/l

0.08

689

Benign neoplasm: Brain, supratentorial

2.41

1.24

1.0

1.3

57.33

78.35

u/l

—

Diseases of the ear and mastoid process

437

1978

1.11

1.24

1.3

1.2

91.84

94.25

u/l

0.14

374

1698

Internal derangement of knee

118

968

1.21

1.22

1.2

1.3

95.56

98.30

u/l

0.07

817

Herpesviral [herpes simplex] infections, including avohilmo

726

1.24

1.21

1.2

88.47

86.64

u/l

0.07

624

Benign neoplasm: Kidney

1.80

1.21

1.4

1.2

97.29

75.87

u/l

0.98

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

124

1.62

1.20

1.1

1.2

100.36

106.92

u/l

0.14

105

Other bursopathies

348

1.35

1.20

1.4

1.2

92.50

91.50

u/l

0.02

289

Other problems related to primary support group, including family circumstances

199

1.47

1.20

1.1

1.2

121.20

78.10

u/l

0.99

169

Speech and linguistic disorders, excluding more controls

117

1.61

1.17

1.3

1.2

71.64

118.91

u/l

0.65

106

Strabismus

719

1.24

1.16

1.3

1.2

126.10

88.87

u/l

1.00

611

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

185

1548

1.15

1.12

1.2

75.05

97.62

u/l

3.98

163

1313

Chronic iridocyclitis

103

1.66

1.12

1.1

1.2

84.76

83.17

u/l

0.03

Other disorders of bladder

242

1.41

1.11

1.3

1.2

112.17

88.13

u/l

0.49

200

Childhood allergy (age < 16)

171

1.45

1.11

1.2

1.3

62.46

83.34

u/l

0.48

155

Early syphilis

2.40

1.09

1.0

1.2

192.00

92.53

u/l

—

Allergic contact dermatitis due to drugs in contact with skin

1.96

1.09

1.4

1.1

90.75

86.46

u/l

—

Congenital malformations of the circulatory system

311

1.34

1.08

1.5

1.2

125.41

103.83

u/l

0.23

261

Cervical disc disorders

124

1048

1.18

1.08

1.3

78.78

96.91

u/l

1.45

106

887

Certain zoonotic bacterial diseases, including avohilmo

1.87

1.07

1.2

156.64

87.13

u/l

0.53

Striking against or struck by other objects

104

864

1.20

1.07

1.3

112.14

90.17

u/l

0.69

737

Benign neoplasm: Other and unspecified parts of small intestine

2.13

1.06

1.0

1.2

68.29

86.86

u/l

—

Optic atrophy, wide definition

2.13

1.05

1.3

1.2

152.71

78.64

u/l

—

Corns and callosities

145

1.52

1.05

1.5

1.2

98.18

83.97

u/l

0.19

123

Whooping cough, including avohilmo

2.28

1.03

1.8

1.1

93.00

59.65

u/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

490

1.27

1.03

1.1

1.2

82.27

78.29

u/l

0.14

428

Pneumothorax

138

1.53

1.02

1.4

1.2

108.00

96.95

u/l

0.15

116

Superficial injury of ankle and foot

272

1.36

1.02

1.4

1.2

67.97

83.47

u/l

1.33

232

Acute nephritic syndrome

1.93

1.02

1.4

1.1

92.22

77.45

u/l

—

Colon adenocarcinoma, helper endpoint

324

1.33

1.02

1.1

1.2

123.86

95.44

u/l

0.59

269

Cluster headache, strict

1.77

1.00

1.5

1.1

68.83

87.68

u/l

0.60

Other extrapyramidal and movement disorders in other diseases

763

1.21

1.00

1.3

1.2

73.22

89.35

u/l

1.21

640

Wide developmental disorders

1.88

1.00

1.5

1.2

72.10

71.87

u/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

2.01

1.00

1.1

63.14

66.10

u/l

—

Leiomyoma of uterus

254

1270

1.12

0.99

1.3

1.2

79.43

86.76

u/l

0.75

223

1098

Alzheimer’s disease (Late onset)

593

0.79

0.99

1.1

1.2

86.75

100.42

u/l

0.43

501

Obstructed labour due to malposition and malpresentation of fetus

551

0.77

0.98

1.2

70.10

91.36

u/l

1.23

479

Chronic laryngitis and laryngotracheitis

406

1.28

0.97

1.2

80.02

89.12

u/l

0.47

343

Disorders of vestibular function (Vertigo)

182

1558

1.14

0.97

1.2

90.27

89.68

u/l

0.02

157

1321

Type of accident

859

0.81

0.96

1.3

1.2

142.30

90.04

u/l

1.10

724

Infective dermatitis

267

1.35

0.95

1.2

83.54

88.89

u/l

0.16

228

Benign paroxysmal vertigo

113

960

1.18

0.95

1.3

1.2

86.43

87.04

u/l

0.02

819

Inflammatory diseases of female pelvic organs

242

1479

1.12

0.95

1.3

1.2

81.81

83.83

u/l

0.14

206

1291

Any dementia

112

911

0.85

0.95

1.2

99.35

97.62

u/l

0.05

778

Other strabismus

557

1.24

0.95

1.4

1.2

116.36

86.45

u/l

0.60

477

Diseases of middle ear and mastoid

186

1338

1.14

0.94

1.3

1.2

91.45

88.69

u/l

0.10

170

1130

Fistulae involving female genital tract

1.90

0.94

1.1

1.2

49.86

58.26

u/l

—

Burns and corrosions of multiple and unspecified body regions

1.90

0.94

1.4

1.1

266.57

79.81

u/l

—

Effects of foreign body entering through natural orifice

596

1.23

0.94

1.2

1.3

83.18

93.36

u/l

0.44

498

Other meningitis

2.15

0.91

1.0

1.3

123.50

83.87

u/l

—

Combinations of oral blood glucose lowering drugs

808

1.19

0.91

1.3

111.80

89.97

u/l

0.92

676

Other disorders of breast

401

1.27

0.91

1.3

1.2

78.61

81.73

u/l

0.08

349

Other sleep disorders

287

1.33

0.91

1.2

79.90

93.36

u/l

0.45

244

Car occupant injured in other and unspecified transport accidents

446

1.26

0.90

1.3

1.2

108.09

92.34

u/l

0.25

385

Pollen allergy

405

1.27

0.90

1.2

85.95

86.85

u/l

0.02

352

Tonsillectomy and adenotomy

135

1082

0.87

0.89

1.3

1.2

79.39

91.78

u/l

0.83

119

937

Unspecified event, undetermined intent

1.91

0.88

1.1

1.3

78.12

79.69

u/l

—

Glucosamine medication

149

1358

0.87

0.88

1.2

80.00

94.39

u/l

1.77

118

1159

Long labour

543

0.79

0.87

1.4

1.2

82.41

87.25

u/l

0.20

470

Carcinoma in situ of breast, other/unspecified

2.01

0.87

1.5

1.2

45.33

76.04

u/l

—

Glaucoma

219

1666

1.12

0.87

1.3

1.2

99.05

92.21

u/l

0.35

186

1418

Other articular cartilage disorders

2.01

0.87

1.0

1.1

79.17

71.84

u/l

—

Mental and behavioural disorders due to tobacco

203

1.38

0.87

1.3

1.2

87.30

81.75

u/l

0.15

167

Spontaneous abortion

130

1003

0.87

0.86

1.3

1.2

69.08

83.08

u/l

1.90

122

865

Focal brain injury

136

1.47

0.86

1.1

1.3

108.00

94.48

u/l

0.18

106

Contact with and exposure to communicable diseases

690

0.81

0.86

1.3

1.2

126.96

89.62

u/l

0.54

596

Paralytic strabismus

153

1.44

0.85

1.3

1.2

157.76

90.24

u/l

0.96

127

Pathological resorption of teeth

1.67

0.85

1.3

1.2

98.17

74.10

u/l

0.48

Optic atrophy

1.94

0.84

1.3

164.00

79.62

u/l

—

Migraine without aura

505

1.23

0.84

1.2

84.15

86.24

u/l

0.07

441

Coxibs

410

1.19

0.84

1.1

1.3

77.67

101.43

u/l

1.74

367

Artrosis, including avohilmo

299

1490

1.10

0.83

1.2

1.3

91.41

99.48

u/l

0.55

255

1277

Alcohol abuse, main dg, excluding more controls

318

1.29

0.83

1.1

1.3

122.79

98.56

u/l

0.43

270

Smoking dependency

205

1.37

0.83

1.3

1.2

87.30

82.17

u/l

0.14

168

Other maternal disorders predominantly related to pregnancy

167

1179

0.89

0.82

1.3

1.2

80.53

82.98

u/l

0.18

152

1022

Hypersensitivity pneumonitis due to organic dust

1.88

0.82

1.2

1.3

208.33

86.59

u/l

—

Malignant neoplasm of tonsil and base of tongue

1.88

0.82

1.0

1.1

102.00

82.64

u/l

—

Alzheimer’s disease, strict definition

636

0.82

0.81

1.1

1.2

82.10

100.12

u/l

0.75

537

Congenital malformations of heart and great arteries

267

1.31

0.81

1.4

1.2

140.20

102.06

u/l

0.36

226

Nasal polyp

509

1.22

0.79

1.3

1.2

110.32

94.03

u/l

0.47

426

Intussusception

1.82

0.79

1.2

76.50

72.75

u/l

—

Intentional self-harm by sharp object

1.82

0.79

1.0

1.2

247.50

88.71

u/l

—

Intracerebral haemorrhage

304

1.28

0.77

1.4

1.2

135.53

91.58

u/l

0.51

259

Focal epilepsy, strict definition

511

1.21

0.77

1.2

149.73

91.02

u/l

1.47

428

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

448

1.23

0.76

1.2

101.04

85.80

u/l

0.33

386

Iridocyclitis in diseases classified elsewhere

1.77

0.76

1.2

96.00

79.52

u/l

—

Melanocytic naevi of other and unspecified parts of face

132

1.44

0.76

1.5

1.2

104.86

80.41

u/l

0.88

114

All dysplastic lesions of the cervix uteri, vagina or vulva

741

1.17

0.75

1.2

80.18

84.87

u/l

0.21

639

Use of antiglaucoma preparations and miotics

192

1.36

0.75

1.2

102.57

83.26

u/l

0.56

158

Early syphilis, including avohilmo

2.09

0.74

1.0

1.2

192.00

86.22

u/l

—

Shoulder region

2.09

0.74

1.8

1.3

43.40

86.42

u/l

—

malignant neoplasm of female genital organs, including Hilmo

472

1.21

0.74

1.3

1.2

107.89

75.61

u/l

1.65

405

Laparoscopic left hemicolectomy

1.85

0.73

1.1

73.29

83.91

u/l

—

Open wound of wrist and hand

140

1198

1.13

0.72

1.3

103.85

94.52

u/l

0.33

121

1016

Supplementary factors related to causes of morbidity and mortality classified elsewhere

915

0.85

0.72

1.3

1.2

134.52

89.43

u/l

1.01

773

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

363

1.20

0.71

1.3

1.2

69.35

87.46

u/l

0.98

320

Suppurative and unspecified otitis media

101

775

1.15

0.71

1.4

1.2

90.27

85.81

u/l

0.12

657

Presbycusis

402

1.23

0.71

1.1

1.2

93.98

104.97

u/l

0.32

335

Noninflammatory disorders of female genital tract

114

655

0.87

0.71

1.2

1.3

91.62

88.43

u/l

0.08

100

556

Other predominantly sexually transmitted diseases, not elsewhere classified

381

1.23

0.70

1.2

96.22

88.75

u/l

0.13

328

Postprocedural musculoskeletal disorders, not elsewhere classified

178

1.35

0.68

1.4

1.2

85.13

84.85

u/l

0.01

153

Malignant neoplasm of rectosigmoid junction

1.86

0.68

1.0

1.1

64.60

89.64

u/l

—

Other and unspecified injuries of ankle and foot

1.56

0.68

1.3

1.2

79.42

84.63

u/l

0.06

Procedures for purposes other than remedying health state

1.67

0.68

1.1

1.2

125.29

68.89

u/l

—

Subarachnoid haemorrhage

262

0.72

0.68

1.2

107.64

83.42

u/l

1.23

218

Adenocarcinoma of pancreas

1.63

0.67

1.3

1.1

192.00

103.97

u/l

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

832

0.85

0.66

1.3

1.2

89.37

92.19

u/l

0.10

698

Anti-inflammatory and antirheumatic products, non-steroids

427

1.16

0.66

1.2

104.90

100.00

u/l

0.12

383

Acute appendicitis, no complications

182

1639

1.10

0.65

1.2

1.3

98.87

93.25

u/l

0.24

158

1392

Antenatal screening

346

0.82

0.65

1.3

60.27

90.51

u/l

4.55

311

Excessive earwax

197

1957

0.91

0.64

1.2

1.3

83.70

96.47

u/l

1.19

170

1675

Other disorders of penis

215

1.30

0.64

1.4

1.3

160.68

105.57

u/l

0.58

174

Medial epicondylitis

1.50

0.63

1.1

1.2

95.25

83.90

u/l

—

Diseases of male genital organs

141

633

1.12

0.63

1.3

106.91

107.68

u/l

0.02

116

544

Early lumbar disc prolapse operation

200

0.70

0.62

1.1

1.2

98.33

104.38

u/l

—

169

Prolapse and hernia of ovary and fallopian tube

102

0.58

0.62

1.3

1.2

66.00

82.44

u/l

—

Any dementia, excluding more controls

102

795

0.88

0.61

1.2

97.63

96.47

u/l

0.03

680

Speech and linguistic disorders

149

1.35

0.61

1.3

1.2

157.80

112.52

u/l

0.20

134

Other peripheral vertigo

235

1.28

0.61

1.2

78.08

81.24

u/l

0.09

201

Uterine polyps

115

594

1.13

0.61

1.2

72.88

92.13

u/l

1.70

102

502

Impacted cerumen

289

1.25

0.60

1.1

1.2

63.33

87.97

u/l

2.33

243

Medical abortion

240

1195

1.09

0.60

1.3

1.2

89.84

83.78

u/l

0.38

210

1029

Cerebral aneurysm, nonruptured

218

1.29

0.60

1.3

1.2

81.05

79.03

u/l

0.09

191

Polyp of the female genital tract

119

598

1.13

0.59

1.2

1.3

76.82

92.03

u/l

1.19

105

505

Inflammatory disease of uterus

344

1.22

0.59

1.3

1.2

67.11

81.68

u/l

1.06

301

Major anomalies of jaw size

1.54

0.59

1.0

1.2

64.63

71.68

u/l

—

Alopecia areata

1.54

0.59

1.1

1.2

98.13

88.09

u/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

472

1.19

0.59

1.3

1.2

144.00

92.06

u/l

1.16

393

Blepharochalasis

993

0.88

0.59

1.3

1.2

94.97

84.92

u/l

0.31

846

Malignant neoplasm of tonsil and base of tongue, including Hilmo

1.67

0.56

1.0

1.1

102.00

78.39

u/l

—

Other obstetric conditions, not elsewhere classified

380

1.16

0.56

1.3

68.71

87.85

u/l

1.11

336

Use of galantamine

183

0.71

0.55

1.2

1.3

76.77

100.94

u/l

0.78

155

Achilles tendinitis

275

1.24

0.55

1.2

100.92

88.24

u/l

0.24

229

Lyme disease

120

1078

1.11

0.54

1.3

75.66

88.19

u/l

1.24

103

910

Lyme disease, including avohilmo

120

1078

1.11

0.54

1.3

75.66

88.19

u/l

1.24

103

910

All dysplastic lesions of the cervix uteri

616

1.15

0.54

1.3

1.2

77.75

85.01

u/l

0.31

537

Other specified/unspecified soft tissue disorders

1.42

0.54

1.4

1.2

98.71

77.92

u/l

0.45

Other spirochaetal diseases

121

1090

1.11

0.53

1.2

1.3

77.34

87.98

u/l

0.94

104

920

Lichen planus, including avohilmo

600

1.15

0.52

1.2

93.69

90.10

u/l

0.12

508

Salpingitis and oophoritis

563

1.16

0.52

1.5

1.2

80.62

82.65

u/l

0.08

485

Polycystic ovarian syndrome, broad definition

169

0.71

0.51

1.3

1.2

94.25

73.94

u/l

0.61

145

Drug-induced adrenocortical insufficiency

1.50

0.51

1.2

1.3

95.00

98.43

u/l

—

Spirochaetal infections, other/unspecified, including avohilmo

120

1083

1.11

0.51

1.3

75.66

88.10

u/l

1.23

103

913

Schizophrenia or delusion

865

1.12

0.51

1.1

1.2

73.52

90.92

u/l

1.69

741

Obstructed labour due to maternal pelvic abnormality

509

0.84

0.49

1.4

1.2

71.26

84.38

u/l

0.74

441

Additional codes for the location of defect, injury or illness

127

1.34

0.49

1.4

1.2

56.76

85.89

u/l

2.19

111

Schizophrenia, schizotypal and delusional disorders

868

1.12

0.49

1.1

1.2

75.62

90.49

u/l

1.26

745

Keratoconus

1.56

0.49

1.1

1.2

140.00

79.17

u/l

—

Other noninflammatory disorders of vulva and perineum

289

1.21

0.48

1.2

73.18

94.54

u/l

1.17

244

Postmenopausal atrophic vaginitis

115

564

1.11

0.48

1.2

70.72

89.57

u/l

1.49

101

479

Bicipital tendinitis

107

0.65

0.48

1.1

1.2

125.43

79.42

u/l

—

Coxarthrosis, primary

228

1762

1.07

0.48

1.3

1.2

89.75

94.12

u/l

0.22

201

1498

Injuries to the neck

586

1.14

0.48

1.3

1.2

80.94

93.19

u/l

0.54

496

Chronic mastoiditis

1.49

0.47

1.0

1.3

112.29

81.34

u/l

—

Extrapyramidal and movement disorders

136

1242

1.10

0.47

1.3

81.68

92.53

u/l

0.70

114

1051

Psoriasis (vulgaris), strict definition

1.47

0.47

1.2

1.1

90.40

89.64

u/l

—

Deviated nasal septum

101

908

1.11

0.47

1.4

1.2

79.86

97.98

u/l

1.24

769

Migraine

172

1235

1.08

0.46

1.3

82.73

92.40

u/l

0.88

145

1072

Tooth agenesis EXCLUDE clefts and syndromes

1.43

0.46

1.1

1.2

285.57

82.27

u/l

—

Other conjunctival vascular disorders and cysts

1.40

0.45

1.1

1.2

47.86

76.69

u/l

—

Secondary polycythaemia

1.40

0.45

1.0

1.2

62.00

76.17

u/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.40

0.45

1.0

1.1

81.43

93.88

u/l

—

Impingement syndrome of shoulder

675

1.13

0.45

1.2

1.3

91.71

93.24

u/l

0.04

574

Other spirochaetal diseases, including avohilmo

121

1104

1.10

0.44

1.2

1.3

77.34

88.17

u/l

0.97

104

933

Benign neoplasm: Conjunctiva

1.45

0.44

1.5

1.2

73.60

82.66

u/l

—

Exposure to other and unspecified animate mechanical forces

1.37

0.44

1.1

1.2

77.43

81.80

u/l

—

Superficial injury of forearm

211

1.23

0.43

1.2

91.05

90.88

u/l

0.00

173

Primary gonarthrosis, bilateral

203

1585

1.07

0.43

1.2

1.3

87.24

94.13

u/l

0.38

168

1354

Pyogenic granuloma

1.62

0.43

1.4

1.2

72.80

77.50

u/l

—

Benign lipomatous neoplasm

913

0.90

0.42

1.1

1.2

70.53

91.52

u/l

2.18

763

Hypothermia

1.57

0.42

1.2

1.3

125.20

78.00

u/l

—

Cluster headache, strict, including avohilmo

1.36

0.41

1.5

1.1

69.46

85.68

u/l

0.57

Benign mammary dysplasia

444

1.15

0.41

1.4

1.2

75.00

83.54

u/l

0.24

380

Endocrine disorders, other/unspecified

1.52

0.41

1.4

1.2

43.80

73.21

u/l

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.41

0.0

1.1

—

71.11

—

Gestational [pregnancy-induced] hypertension

646

0.88

0.41

1.1

1.2

58.52

86.97

u/l

5.26

556

Alcohol abuse, main dg

351

1.17

0.41

1.1

1.2

122.79

96.46

u/l

0.48

288

Oxicams

363

1.13

0.41

1.1

1.3

85.27

107.28

u/l

1.25

322

Outcome of delivery

243

1.16

0.40

1.2

1.3

69.76

93.16

u/l

1.85

216

HSIL lesion of the vulva

1.47

0.40

1.0

1.2

73.60

74.25

u/l

—

Muscle strain

1.34

0.40

1.5

1.2

48.38

80.63

u/l

—

Other symptoms and signs involving the digestive system and abdomen

464

1.14

0.40

1.3

1.2

124.51

82.63

u/l

1.10

400

Contraceptive management

117

892

0.92

0.40

1.4

1.2

73.83

91.39

u/l

1.85

105

772

Maternal care for known or suspected abnormality of pelvic organs

444

0.88

0.40

1.3

1.2

70.60

86.10

u/l

0.84

393

Injury of muscle and tendon at hip and thigh level

232

1.21

0.39

1.1

1.2

59.33

86.45

u/l

2.15

195

Normal-pressure hydrocephalus

102

0.69

0.39

1.0

1.2

111.71

94.69

u/l

—

Bell's palsy

297

1.18

0.39

1.2

81.76

96.07

u/l

0.54

247

Other disorders of conjunctiva

381

1.16

0.39

1.5

1.2

106.00

87.06

u/l

0.26

320

therapeutic use

1.37

0.38

1.6

1.2

124.56

78.75

u/l

—

Vasomotor and allergic rhinitis

118

1061

1.09

0.38

1.3

1.2

81.78

95.02

u/l

0.85

104

896

Viral meningitis, including avohilmo

1.33

0.37

1.2

200.89

86.29

u/l

—

Lesion of ulnar nerve

374

1.15

0.36

1.2

81.27

92.50

u/l

0.58

313

Disorder of external ear, unspecified

1.29

0.36

1.2

106.11

78.85

u/l

—

Injury of muscle and tendon at shoulder and upper arm level

1080

0.92

0.36

1.2

1.3

106.20

94.67

u/l

0.39

905

Acute alcohol intoxication

630

1.11

0.36

1.1

1.3

110.12

101.94

u/l

0.16

531

Chronic diseases of tonsils and adenoids

244

1625

0.95

0.36

1.3

1.2

77.57

95.25

u/l

1.66

214

1389

Carcinoma in situ, bladder

0.66

0.35

1.2

86.20

98.80

u/l

—

Respiratory conditions due to other external agents

1.43

0.35

1.5

1.2

86.00

75.28

u/l

—

Contact with nonpowered hand tool

0.63

0.35

1.0

1.2

81.60

91.16

u/l

—

Later onset COPD

644

1.10

0.35

1.1

1.2

101.16

102.34

u/l

0.03

542

Alzheimer’s disease (Late onset), excluding more controls

278

0.86

0.35

1.1

1.3

76.39

104.53

u/l

0.72

233

Other degenerative diseases of the nervous system

599

1.10

0.34

1.3

1.2

86.30

96.12

u/l

0.39

513

Injury of muscle and tendon at lower leg level

358

1.15

0.34

1.6

1.2

103.38

95.39

u/l

0.15

297

Spermatocele

154

1.24

0.34

1.1

1.3

129.77

103.89

u/l

0.20

121

Acute appendicitis

229

2013

1.06

0.33

1.3

104.95

93.42

u/l

0.72

202

1723

Mental and behavioural disorders due to cannabinoids

1.31

0.33

1.0

1.3

77.67

84.31

u/l

—

Early lumbar disc prolapse, operated

177

0.79

0.33

1.1

1.2

98.33

109.86

u/l

—

147

Fitting and adjustment of other devices

899

0.92

0.32

1.1

1.2

98.17

91.86

u/l

0.28

754

Ectopic pregnancy

540

0.89

0.32

1.1

1.2

61.57

82.26

u/l

2.08

462

Cervical polyps

327

0.86

0.31

1.1

1.3

96.78

88.25

u/l

0.18

273

Nontoxic goitre/thyroid nodule

108

1002

1.08

0.31

1.2

67.53

86.41

u/l

2.78

856

Juvenile osteochondrosis

1.35

0.31

1.4

1.2

48.29

75.65

u/l

—

Diseases of appendix

246

2095

1.05

0.30

1.3

102.05

92.83

u/l

0.58

219

1792

Unspecified abortion

138

1.23

0.30

1.5

1.1

94.65

80.41

u/l

0.23

117

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

138

1.23

0.30

1.3

1.2

54.08

85.70

u/l

3.29

117

Appendicitis, broad definition

244

2086

1.05

0.30

1.3

102.53

92.94

u/l

0.61

217

1785

Dentofacial anomalies [including malocclusion]

223

1831

0.95

0.29

1.2

1.3

99.26

89.34

u/l

0.21

192

1586

Pregnancy with abortive outcome

220

1205

0.95

0.29

1.2

81.91

83.59

u/l

0.10

193

1037

Primary open-angle glaucoma

1005

0.93

0.29

1.3

1.2

100.79

94.65

u/l

0.18

848

Other sexually transmitted chlamydial diseases, including avohilmo

139

1.22

0.29

1.1

1.2

83.33

88.92

u/l

0.12

126

Other obstetric trauma

1.28

0.28

1.3

1.2

87.50

95.57

u/l

0.08

Oligomenorrhoea

1.27

0.27

1.4

1.2

93.75

70.60

u/l

—

Glaucoma-related operations

140

1.22

0.27

1.1

1.2

143.90

81.56

u/l

—

119

Viral meningitis

1.23

0.27

1.3

1.2

212.50

88.36

u/l

—

Other benign neoplasms of skin

128

1205

1.06

0.26

1.4

1.2

93.78

91.29

u/l

0.08

110

1018

Pain associated with micturition

319

1.13

0.26

1.2

57.68

89.57

u/l

3.11

269

Injury of nerves at wrist and hand level

0.67

0.26

1.0

1.2

70.00

79.32

u/l

—

Supervision of normal pregnancy

333

0.91

0.25

1.2

1.3

62.13

89.19

u/l

3.73

300

Postmenopausal bleeding

114

559

1.07

0.25

1.2

78.55

89.63

u/l

0.82

101

474

Other noninflammatory disorders of uterus, except cervix

552

1.08

0.25

1.2

76.58

88.26

u/l

0.96

468

Hydrocele

254

1.14

0.25

1.1

1.3

99.45

107.14

u/l

0.13

207

Allergic rhinitis

819

1.07

0.25

1.2

83.38

92.68

u/l

0.42

705

Puerperal sepsis

424

0.90

0.24

1.3

1.2

73.82

83.19

u/l

0.39

370

Vascular dementia

218

1.15

0.24

1.1

1.2

146.65

106.46

u/l

0.35

185

Other acquired deformities of musculoskeletal system and connective tissue

1.25

0.24

1.3

1.2

110.42

82.40

u/l

0.62

Complications predominantly related to the puerperium

725

0.92

0.24

1.3

1.2

70.92

82.22

u/l

0.84

629

Use of ropinirole

0.72

0.24

1.5

1.2

64.83

82.59

u/l

—

Persons encountering health services in circumstances related to reproduction

194

1243

1.05

0.23

1.3

89.62

94.41

u/l

0.18

167

1080

Varicose veins

219

1586

1.04

0.23

1.3

1.2

93.81

92.30

u/l

0.08

185

1359

Cervicobrachial syndrome

620

1.08

0.23

1.1

1.3

78.12

91.37

u/l

0.80

523

Acetic acid derivatives and related substances

404

1.07

0.23

1.1

1.3

107.75

102.44

u/l

0.13

361

Female infertility, cervical, vaginal, other or unspecified origin

507

1.07

0.23

1.2

1.3

80.30

91.78

u/l

0.69

433

Use of levodopa decarboxylase inhibitor

361

1.11

0.22

1.4

1.2

93.18

94.78

u/l

0.03

300

Propionic acid derivatives

427

0.93

0.22

1.1

1.2

111.39

100.00

u/l

0.24

383

Migraine without aura and triptan purchases

419

1.10

0.22

1.2

74.60

81.30

u/l

0.32

364

Glaucoma, exfoliation

284

0.88

0.22

1.1

1.2

143.50

87.29

u/l

0.66

234

Impacted maxillary canine

0.00

0.21

0.0

1.1

—

47.55

—

Excessive, frequent and irregular menstruation

129

653

1.05

0.21

1.2

1.3

84.32

88.52

u/l

0.20

115

555

Benign neoplasm: Cerebral meninges

262

0.88

0.21

1.4

1.2

85.25

77.60

u/l

0.29

226

Other melanin hyperpigmentation

1.25

0.20

1.3

1.2

52.17

91.60

u/l

—

Lateral epicondylitis

376

0.90

0.20

1.2

65.41

86.37

u/l

1.34

319

Menorrhagia

118

624

1.05

0.20

1.2

1.3

85.68

90.86

u/l

0.23

107

529

Gestational diabetes (for exclusion)

596

1.06

0.20

1.3

1.2

76.89

85.28

u/l

0.60

519

Foreign body on external eye

313

0.89

0.20

1.1

1.2

79.61

101.82

u/l

0.52

262

Atrial septal defect, secundum type

1.15

0.19

2.0

1.2

295.83

86.89

u/l

—

Pedal cyclist injured in noncollision transport accidents

280

1.11

0.18

1.2

105.48

94.60

u/l

0.23

236

Pre-eclampsia or poor fetal growth

803

0.94

0.18

1.4

1.2

72.25

85.56

u/l

1.39

699

Artificial joint operation, meniscal resection

317

2084

0.97

0.18

1.2

1.3

86.70

97.00

u/l

1.19

273

1795

Other and unspecified degenerative diseases of nervous system

1.21

0.18

1.7

1.2

93.71

93.08

u/l

—

Dislocation, sprain and strain of joints and ligaments of knee

188

1638

1.04

0.18

1.3

82.31

89.90

u/l

0.58

159

1402

Parkinson's disease, including avohilmo

414

0.92

0.17

1.3

1.2

100.90

92.60

u/l

0.16

344

Benign neoplasm: other/unspecified salivary gland

1.15

0.17

1.3

1.2

116.00

78.98

u/l

—

Lichen sclerosus et atrophicus

358

1.09

0.17

1.1

1.2

64.63

81.81

u/l

1.23

304

Serous carcinoma of ovary, including Hilmo

0.76

0.17

1.6

1.2

91.80

75.31

u/l

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

446

1.08

0.16

1.2

136.19

84.67

u/l

1.42

370

Benign neoplasm: Other and unspecified parts of mouth

1.16

0.16

1.4

1.2

69.38

86.38

u/l

—

Parkinson's disease, strict definition, excluding more controls

299

1.09

0.16

1.4

1.3

100.76

102.18

u/l

0.02

253

Subacute thyroiditis

1.14

0.16

1.3

1.2

67.88

76.12

u/l

—

Antepartum haemorrhage, not elsewhere classified

172

0.87

0.15

1.1

1.3

66.40

86.14

u/l

—

154

Acute alcohol intoxication, ICD10

477

1.07

0.15

1.1

1.2

121.49

99.48

u/l

0.40

398

Benign neoplasm: Skin of ear and external auricular canal

0.75

0.15

2.2

1.2

125.67

95.59

u/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

137

1233

0.96

0.15

1.2

66.10

85.74

u/l

3.56

126

1066

Other menopausal disorders

105

559

1.05

0.15

1.2

1.3

73.07

91.40

u/l

1.46

472

Aneurysms, operations, SAH

462

0.93

0.15

1.2

91.27

87.97

u/l

0.15

390

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

369

0.92

0.15

1.1

1.2

79.28

90.75

u/l

0.33

311

Tinnitus

761

1.05

0.15

1.2

77.35

89.80

u/l

0.83

638

Traumatic amputation of wrist and hand

0.79

0.14

1.3

1.2

129.86

96.47

u/l

—

Peritonsillar abscess

502

0.94

0.14

1.2

109.80

93.64

u/l

0.21

417

Endometriosis of pelvic peritoneum

437

0.94

0.14

1.2

1.3

80.87

95.14

u/l

0.68

373

malignant neoplasm of female genital organs

421

1.07

0.14

1.3

1.2

105.98

75.19

u/l

1.12

361

Female infertility

515

1.05

0.14

1.2

1.3

78.60

91.59

u/l

0.85

441

Pain and other conditions associated with female genital organs and menstrual cycle

482

1.06

0.14

1.1

1.3

98.54

90.51

u/l

0.13

411

Pedal cyclist injured in transport accident

617

1.05

0.13

1.4

1.2

91.67

89.76

u/l

0.06

524

Coxarthrosis, primary, with hip surgery

167

1502

1.03

0.13

1.3

1.2

90.73

94.32

u/l

0.14

147

1271

Alzheimer’s disease (Early onset)

107

0.84

0.13

1.1

1.2

58.67

98.54

u/l

—

Presence of other devices

637

1.05

0.13

1.3

1.2

93.22

92.00

u/l

0.04

529

Glaucoma suspect

128

1238

1.03

0.12

1.2

95.65

88.54

u/l

0.26

107

1043

Gonarthrosis, primary, with knee surgery

206

1642

0.98

0.11

1.2

1.3

84.76

95.72

u/l

0.93

176

1405

Primary open-angle glaucoma, strict

831

0.96

0.11

1.3

1.2

97.84

92.60

u/l

0.15

693

Disorders of refraction and accommodation

804

1.04

0.11

1.3

1.2

109.78

86.25

u/l

0.45

692

Parkinson's disease, excluding more controls

328

1.07

0.11

1.3

100.90

100.42

u/l

0.01

278

Lichen ruber planus, wide definition including periferal and oral lichen planus

740

1.04

0.10

1.3

1.2

91.28

87.92

u/l

0.12

627

Temporomandibular joint disorders, including avohilmo

140

1318

1.03

0.10

1.2

1.3

70.44

86.49

u/l

1.92

119

1134

Maternal care for known or suspected fetal abnormality and damage

304

1.06

0.09

1.1

1.2

63.76

86.46

u/l

1.28

274

Circumscribed brain atrophy

1.06

0.09

1.4

1.3

104.00

80.07

u/l

—

Primary coxarthrosis, bilateral

929

0.97

0.09

1.3

1.2

79.29

94.11

u/l

1.17

770

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

1.09

0.09

1.0

1.2

98.17

88.27

u/l

—

Moderate visual impairment, binocular

1.07

0.08

1.2

40.17

72.28

u/l

—

Other abnormal uterine and vaginal bleeding

572

0.97

0.08

1.3

1.2

85.69

88.16

u/l

0.10

483

Burn and corrosion of trunk

1.05

0.08

1.3

1.2

59.00

76.73

u/l

—

Hypertrophy of breast in women and men

597

1.04

0.08

1.2

66.39

85.69

u/l

2.23

517

Chondromalacia

0.83

0.08

1.0

1.2

72.00

84.02

u/l

—

Medical treatment for female infertility

426

0.95

0.08

1.3

1.2

67.21

90.61

u/l

1.48

373

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

195

0.92

0.08

1.2

62.54

80.25

u/l

0.83

166

Other disorders of prostate

1.06

0.08

1.7

1.2

90.14

100.24

u/l

—

Anomalies of dental arch relationship, including avohilmo

452

0.96

0.07

1.3

1.2

170.00

83.61

u/l

0.48

393

Parkinson's disease

398

0.95

0.07

1.3

1.2

100.90

92.74

u/l

0.16

332

Endometriosis of ovary

499

1.04

0.07

1.3

94.55

95.51

u/l

0.02

416

Benign leiomyoma with endometriosis

511

1.04

0.07

1.3

1.2

92.70

81.12

u/l

0.29

437

Hypertrophy of breast

531

1.04

0.07

1.2

67.43

84.97

u/l

1.69

462

Benign neoplasm: Skin, unspecified

1.02

0.07

1.4

1.2

74.11

86.36

u/l

—

Irregular menses

157

1158

1.02

0.06

1.2

76.86

83.42

u/l

0.55

139

1003

Triptan medication for migraine, min. 3 purchases

173

1313

0.98

0.06

1.2

77.50

85.67

u/l

0.82

149

1133

Unknown and unspecified causes of morbidity

119

1.09

0.06

1.5

1.2

115.31

77.80

u/l

0.49

Other benign neoplasms of connective and other soft tissue

227

1.06

0.06

1.4

1.2

69.64

82.12

u/l

0.60

195

Organic, including symptomatic, mental disorders

177

1227

1.01

0.05

1.2

92.41

97.51

u/l

0.22

153

1035

Female infertility, associated with anovulation

110

0.91

0.05

1.3

74.80

91.45

u/l

—

Other disorders of ear

329

2106

1.01

0.04

1.3

1.2

89.28

96.34

u/l

0.51

285

1810

Gonarthrosis,primary

325

1942

1.01

0.04

1.2

1.3

87.39

97.25

u/l

0.96

276

1673

Polycystic ovarian syndrome, consortium definition

259

1471

1.01

0.04

1.2

78.99

84.45

u/l

0.50

230

1272

Parkinson's disease, strict definition

361

0.97

0.03

1.4

1.2

100.76

95.98

u/l

0.08

301

Schizophrenia

389

1.03

0.03

1.0

1.2

90.45

92.28

u/l

0.05

330

Pregnancy hypertension

121

1094

0.99

0.03

1.2

69.18

86.19

u/l

2.39

110

948

Other female pelvic inflammatory diseases

471

0.98

0.03

1.3

1.2

81.05

81.14

u/l

0.00

405

Migraine, single triptan purchase ok & required. ICD-code if available is included

251

1710

0.99

0.02

1.3

72.47

90.34

u/l

3.60

219

1479

Triptan medication for migraine, single purchase ok

251

1710

0.99

0.02

1.3

72.47

90.34

u/l

3.60

219

1479

Endometriosis

110

632

1.01

0.02

1.2

1.3

83.44

90.10

u/l

0.36

538

Benign neoplasm of meninges

288

0.97

0.02

1.6

1.2

80.75

84.18

u/l

0.12

250

Nontoxic multinodular goitre

611

1.01

0.02

1.3

1.2

69.12

88.33

u/l

1.56

521

Endometriosis ASRM stages 3,4

651

1.01

0.01

1.3

1.2

93.81

81.28

u/l

0.38

559

Other disorders of eyelid

154

1462

0.99

0.01

1.2

96.48

91.05

u/l

0.21

133

1241

Other symptoms and signs involving the nervous and musculoskeletal systems

127

1278

0.99

0.01

1.4

1.2

100.97

88.91

u/l

0.33

107

1083

Nontraumatic intracranial haemmorrhage

543

1.01

0.01

1.3

1.2

127.57

91.76

u/l

0.58

454

Pre-eclampsia or eclampsia

614

1.01

0.00

1.3

1.2

72.81

85.63

u/l

1.16

528

Inguinal hernia

158

1052

1.00

0.00

1.3

95.69

101.75

u/l

0.25

130

885

Diabetes mellitus in pregnancy

475

1.00

0.00

1.4

1.3

85.22

84.23

u/l

0.03

415

Other condition

356

1.01

0.00

1.3

1.2

193.83

88.52

u/l

1.19

299

Benign neoplasm: Skin of eyelid, including canthus

446

1.01

0.00

1.3

1.2

69.03

91.51

u/l

2.64

380

Chronic suppurative otitis media

137

1.02

0.00

1.7

1.2

149.93

92.08

u/l

0.30

120

Acute lymphadenitis

1.01

0.00

1.5

1.2

100.50

87.37

u/l

—

Alzheimer disease, excluding more controls

333

1.01

0.00

1.2

75.98

97.39

u/l

0.79

280

Supervision of high-risk pregnancy

326

1.00

0.00

1.2

1.3

75.57

89.39

u/l

0.68

294

Dysplasia of cervi uteri

489

1.01

0.00

1.2

1.3

72.54

93.66

u/l

1.31

416

Endometriosis ASRM stages 1,2

471

1.00

0.00

1.2

78.66

81.71

u/l

0.12

415

Normotensive glaucoma

237

1.01

0.00

1.3

101.00

88.61

u/l

0.20

204

Failed induction of labour

0.99

0.00

1.0

1.3

56.38

86.50

u/l

—

Hypospadias

0.00

0.0

1.4

—

53.00

—

Malignant neoplasm of oesophagus, including Hilmo

0.89

-0.00

1.0

1.1

97.00

95.57

u/l

—

Other and unspecified mononeuropathies of upper limb

0.95

-0.00

1.2

73.33

80.18

u/l

—

Alzheimer’s disease (Early onset), excluding more controls

0.97

-0.00

1.1

1.2

58.67

89.23

u/l

—

Congenital malformations of great veins

0.00

-0.00

0.0

1.0

—

115.17

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.1

—

122.71

—

Polycystic ovarian syndrome

0.98

-0.00

1.5

1.2

103.33

90.98

u/l

—

0.00

-0.00

0.0

1.0

—

128.00

—

Oral lichen planus

0.98

-0.00

1.5

1.2

85.50

75.26

u/l

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

-0.00

0.0

1.1

—

112.38

—

Congenital vesicoureteral reflux

0.00

-0.00

0.0

1.0

—

60.17

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.2

—

37.78

—

Other and unspecified syphilis, including avohilmo

0.00

-0.00

0.0

1.4

—

67.00

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

1.0

—

131.60

—

Birth asphyxia

0.00

-0.00

0.0

1.1

—

41.25

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS